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Summary
The cytokine TNFα is a potent effector of inflammation, and is causally involved in toxic 
shock syndrome and rheumatoid arthritis. It is vital to maintain continuous control over 
TNFα levels under continuous control, which can be achieved in one way by regulating the 
decay rate of the TNFα mRNA. One cis-element, the AU-rich element (ARE) in the TNFα 
3’UTR confers to rapid degradation of this message. When the element is knocked out in 
mice, TNFα is overproduced resulting in the corresponding pathology.
We recently described a second cis-element, the constitutive decay element (CDE), that is 
unique to TNFα and, compared to the ARE, is unresponsive to TNFα RNA stabilizing signals 
such as lipopolysaccharide (LPS) or phorbol esters. Furthermore a CDE-bearing reporter 
was degraded in Slow C cells that are defective in ARE dependent decay, implying that CDE 
mediated degradation is performed by a different mechanism. Through deletion mutation we 
were able to define a 40 nucleotide (nt) stretch (fragment O), located 42 nt downstream of the 
ARE, that is the minimal functional CDE. Any mutation to this minimal sequence was not 
only inactive in promoting decay, but also exhibited differences in protein binding compared 
to fragment O. The CDE binding proteins were assayed by UV-crosslinking assays, purified 
by biochemical fractionation and identified by mass spectrometry. The RNA-binding 
protein nucleolin was the prime candidate. We produced full length recombinant nucleolin 
with the baculovirus system, and could demonstrate that recombinant nucleolin binds in 
vitro to fragment O but not its mutated sequences by electrophoretic mobility shift assay. 
The nucleolin-CDE association was also observed with band shift and super shift assays 
in THP-1 human macrophage cytoplasmic extracts. Furthermore we could show by RNA 
immunoprecipitation assays in THP-1 cells, that nucleolin is specifically associated with 
endogenous TNFα mRNA in vivo, but not with the transcripts of IL-6 and IL-10, or 
GAPDH. To assess whether down regulation of nucleolin by RNA interference would affect 
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CDE mediated decay, we transfected nucleolin or control siRNAs into a human HT1080 
GFP-CDE reporter cell line. By FACS we observed an increase in GFP protein levels with 
the nucleolin specific siRNAs but not with the control siRNAs, indicative of elevated CDE-
reporter mRNA levels. Actinomycin D chase experiments confirmed stabilization of the CDE 
reporter with a 40% increase in reporter mRNA half-life from 96+2 min to 135+11 min, that 
was statistically significant. We conclude that nucleolin is associated with the CDE in vitro 
and in vivo and is be functionally involved in the CDE-mediated degradation pathway.
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Abreviations
ARE   AU-rich element
AUBP   ARE binding protein
CDE   Constitutive decay element
CDEBP  CDE binding protein
Cpm   Counts per minute
FACS   Fluorescence activated cell sorter
GAPDH  Glycerine-aldehyde-3-phosphate dehydrogenase
GFP   Green fluorescent protein
GSH   Glutathion
GST   Glutathion-S-transferase
IL-2, 6 or10  Interleukin 2, 6 or 10
IP   Immunoprecipitation
LPS   Lipopolysaccharide
NCL   Nucleolin
NRE   Nucleolin recognition element
PAGE   Polyacrylamide gel electrophoresis
RNAi   RNA interference
RRM   RNA recognition motif
SiRNA  small interfering RNA
TeV   Tobacco etch virus
TNFα   Tumor necrosis factor alpha
UTR   Untranslated region
Less frequently used abbreviations are defined upon their first use in the text.
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1. Introduction
1.1 Life cycle of an mRNA
Messenger RNA is transcription from the genomic DNA template by RNA polymerase 
II (Fig. 1). Whether a specific gene is transcribed or not depends upon the transcription 
factors and transcription enhancer factors present within a certain cell type or situation. By 
regulating these factors, the mRNAs that are needed in response to an external signal can be 
produced when required. To protect mRNA from rapid degradation, it is chemically modified 
on the 5’ end by a 5’-methyl-guanosine cap structure that is attached co-transcriptionally 
and at the 3’ end by the poly (A)-tail consisting of 150 to 250 adenosine residues which are 
added post-transcriptionally by the poly(A)-polymerase after cleavage of the nascent mRNA 
by an endonuclease at a specific signal sequence. During maturation of mRNA, alternative 
events can lead to heterogeneity for a particular mRNA species. One such event is alternative 
splicing. By choosing the exons to be included or omitted, different messages can arise from 
the same transcript and which may even have opposing effects. The current record holder in 
respect to alternative splice forms is the receptor molecule Dscam in Drosophila with 38016 
putative splice forms. Dscam is involved in axon branching in Drosophila and it was shown 
that reduction of the maximal splice forms to 22176 by deletion resulted in axon branching 
defects (Chen, et al. 2006). Another example is the mRNA coding for the RNA-binding 
protein AUF1 that is expressed in four isoforms (Wagner et al. 1998). Two of the resulting 
isoforms, p37 and p42, stabilize their target transcripts whereas the p40 and p45 isoforms 
destabilize them (Raineri et al. 2004). Another step that can be regulated is the export of 
the mRNA. Some messages can be retained in the nucleus, and only be released into the 
cytoplasm upon receipt of a stimulus, as with the Lys2 mRNA in yeast (Das et al. 2006). 
Once exported, the mRNA can direct protein translation by ribosomes, a process which can 
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FIG. 1. Life cycle of a messenger RNA. mRNA is transcribed from genomic DNA by RNA polymerase II. 
The mRNA is then capped at the 5’end and spliced co-transcriptionally. The final step in mRNA maturation is 
polyadenylation by the poly(A) polymerase (PAP), which adds adenosine residues in a template independent 
fashion after an endonucleolytic cut at the polyadenylation site. The fully processed RNA is translation 
competent and is exported into the cytoplasm for translation on ribosomes. Finally, when the lifetime of an 
RNA is over, the mRNA is deadenylated and undergoes degradation by the 5’-3’ or 3’-5’ degradation pathway. 
In the 5’-3’ degradation pathway, the 7-methylguansine-cap structure is cleaved by a decapping enzyme, and 
the unprotected mRNA is subsequently degraded completely by the exonuclease Xrn1. In the 5’-3’ degradation 
pathway, first the poly(A) tail of the mRNA is removed by deadenylases and the RNA body is then degraded by 
the exosome. Finally the remaining 7-methyguanosine-cap structure is cleaved by a scavenging complex.
Introduction
14
Introduction
15
also be regulated by RNA binding proteins or special short micro RNAs (miRNA) (Piecyk 
et al. 2000; Reinhart et al. 2000; Pillai et al. 2005). 
At the end of the mRNA’s live cycle it needs to be degraded. Among the earliest known 
properties of mRNA after its discovery in 1961 in E.coli cells, was its instability with half-
lives in E.coli ranging from 30 seconds to 20 minutes (Gros et al. 1961). In eukaryotic 
cells however, the mRNA half-lives are longer, from about 20 minutes up to more than 24 
hours, and the degradation is executed by different nucleases. In eukaryotes, degradation 
of mRNA is commenced by two different pathways, the 5’-3’ and the 3’-5’ exonucleolytic 
decay pathways. In the 5’-3’ decay pathway, the message is first decapped, and afterwards 
degraded by the exonuclease Xrn1 (Parker and Song 2004). In the 3’-5’ pathway, the mRNA 
has first to be deadenylated by deadenylases before the RNA body can be degraded by 
the exosome. The last step in this pathway is the removal of the 7-methyl guanosine cap 
structure by a decapping enzyme (Parker and Song 2004). The decay kinetics of a specific 
RNA can be further influenced by proteins inducing stabilization or degradation of specific 
mRNAs (Ross 1996). In this work we will mainly concentrate on mRNA turnover, and not 
on the other aspects presented before.
1.2 Posttranscriptional regulation of gene  
      expression
The genetic information of an organism has to be translated into effector molecules, which 
are mainly proteins. The multi-step process of expressing the genetic information from DNA 
to protein has to be regulated so that only the genes that are needed are expressed, and at 
an appropriate level of expression. For example; excess levels of a cleavage product of the 
amyloid precursor protein is a factor in Alzheimer’s disease as reviewed by (Ghribi 2006), 
and various proteins with oncogenic potential are overexpressed in cancer. It is therefore 
of great importance to tightly regulate gene expression on multiple levels. The first stage 
of regulation is at the level of transcription. The transcription rate of certain genes can be 
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altered by extrinsic or intrinsic signals. The kinetics of transcription alone would result in 
a linear increase of mRNA in the presence of continuous signalling until transcription is 
stopped or all cellular resources are exhausted. To counteract this process, and therefore 
limit the amount of mRNA produced and at the same time replenish the stock of building 
blocks, the messages are degraded and so create an equilibrium between transcription and 
degradation. If the message is no longer required, the mRNA can be rapidly cleared after 
transcription is turned off. A good example to illustrate this process is the cytokine TNFα. 
Here the levels of TNFα mRNA increase over 4 hours when macrophages are challenged 
with LPS and decline thereafter again (Stoecklin et al. 2003). Controlling the availability of 
mRNA is a general way to produce certain proteins that are only required at a certain time-
point and for a short period of time 
1.3 Degradation of mRNA in eukaryotes
As previously mentioned, the half-lives of mRNAs transcribed from different genes can vary 
greatly and can be as short as 20 minutes to as long as 24 hours depending on the particular 
mRNA. It was debated for a long time whether mRNA is intrinsically labile and needs 
factors for stabilization or vice versa (Ross 1996). Eventually it became clear that RNA is 
intrinsically quite stable and needs cis- and trans-acting factors to be actively destabilized. 
On the other hand, super-stabilizing elements and factors have also been discovered, which 
will be discussed later. However, all mRNAs, independent of their lifetimes, appear to be 
subjected to common general mechanisms of decay that will be subsequently introduced. 
1.3.1 Deadenylation
The prominent pathways of mRNA degradation in yeast and mammals start with the removal 
of the poly(A)-tail which is carried out by poly(A)-specific exonucleases. Initially, the 
poly(A)-tail is shortened by the Pan2/Pan3 complex (Sachs and Deardorff 1992; Boeck et 
al. 1996; Brown and Sachs 1998). In mammals it was reported that the Pan2/Pan3 complex 
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removes the poly(A) tail leaving 55 to 80 adenosine residues. This shortened poly(A)-tail 
is removed by the Ccr4-NOT complex (Yamashita et al. 2005), consisting of Ccr4p, which 
appears to be the main catalytic protein, that is tightly associated with Caf1p. These two core 
components of the CCR4-Not complex are members of the RNAse D exonuclease family, 
and are in complex with the proteins Not1-5p, Caf4, Caf40 and Caf130p as reviewed in 
(Denis and Chen 2003; Parker and Song 2004). Another poly(A)-specific exonuclease is 
PARN, which was isolated from calf thymus in 1998 and belongs to the RNAse D family 
of exonucleases, as CCR4 and the Caf-proteins (Korner et al. 1998). This protein however 
has no homologue in Saccharomyces cerevisiae or Drosophila melanogaster (Tucker et al. 
2001). It was found to be mainly located in the nucleus, and knock down of PARN levels 
by small interfering RNAs did not have an effect on general deadenylation in the cytoplasm 
(Yamashita et al. 2005). Furthermore it was shown in vitro that PARN interacts with the 
5’-7methylGpppC-cap and the poly(A)-tail at the same time and suggests a link between 
translation and degradation (Dehlin et al. 2000; Gao et al. 2000; Martinez et al. 2001; Seal et 
al. 2005). After deadenylation of an mRNA, the RNA-body is open to total degradation.
1.3.2 Degradation of the RNA body
The RNA body can be degraded after deadenylation by two different enzymatic activities in 
the 5’-3’ and 3’-5’ exonucleolytic pathways. 
The major degradation pathway in yeast is executed by 5’-3’ exonucleases (Tucker et al. 
2001; He et al. 2003; Fritz et al. 2004); however before these enzymes can act, the 7-methyl-
guanosine cap structure has to be removed. The cap structure is cleaved by a complex 
consisting of the decapping enzymes Dcp1 and Dcp2, which are accompanied by the RNA 
helicase dhh1 (Muhlrad and Parker 1994; Fillman and Lykke-Andersen 2005). The exposed 
RNA body is subsequently digested by the Xrn1 and Rat1 proteins (Fritz et al. 2004). These 
two proteins are also present in higher eukaryotes, where the homologue of Rat1p is mainly 
localized in the nucleus. 
A second pathway leads to 3’ to 5’ degradation of RNA via the exosome (Mitchell et al. 
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1996; Mitchell et al. 1997; Allmang et al. 1999b). The exosome is not only involved in the 
degradation of mRNA in the cytoplasm after deadenylation, but also plays a very important 
role in the maturation of ribosomal RNA in the nucleolus (Allmang et al. 1999a; Allmang et 
al. 2000), of small nucleolar RNA, of small nuclear RNA (Allmang et al. 1999a), and in the 
quality control of mRNAs that are aberrantly spliced (Hilleren and Parker 2003). In contrast 
to the hydrolytic exonuclease involved in the 5’ to 3’ RNA decay, these enzymes need ATP 
for phosphorolytic cleavage (Anderson and Parker 1998). The exosome is organized in a 
multimeric complex forming a ring-like structure (Fig. 2) (Lorentzen et al. 2005), similar 
to E.coli RNAse PH (Symmons et al. 2000). The core components of the human exosome 
are hRrp41p, hRrp42p, hRrp46p, OIP2, hMtr3p and PM/Scl75. This core associates 
with the proteins hRpr4p, hRpr40 and hCsl4p (Raijmakers et al. 2002a; Raijmakers et 
al. 2002b; Raijmakers et al. 2003; Raijmakers et al. 2004) that carry S1 RNA binding 
FIG. 2. The exosome. The core exosome 
consists of the phosphorolytic nucleases 
hRrp41, hRrp42p, hMtr3p, OIP2, hRrp46p 
and PM/Scl75, which form a ring-like 
structure. This core is surrounded by the 
hydrolytic nucleases hRrp4p, Rrp40p and the 
RNA-binding protein hCsl4p.
domains. Knockouts of the homologous components in yeast (Rrp4p, Rrp41p, Rrp44p and 
Ski4p/Csl4p) are viable, and reconstitution of the exosome with the corresponding human 
homologue of the deleted protein was possible, suggesting a strong conservation of this 
structure (Mitchell et al. 1997; Allmang et al. 1999b), as supported by the homologues of 
the exosome components in Arabidopsis thaliana (Chekanova et al. 2000; Chekanova et 
al. 2002), Trypanosoma brucei (Estevez et al. 2001; Estevez et al. 2003) and Drosophila 
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melanogaster (Andrulis et al. 2002). In addition, the exosome is associated with the Ski-
complex in the cytoplasm (Ski2p, Ski3p, Ski8p) and Ski7p (Brown et al. 2000; Araki et al. 
2001), in the nucleus (PM/Scl100, Rrp47p and hMtr4p) and in the nucleolus (Rrp14 and 
PM/Scl100) (de la Cruz et al. 1998; Allmang et al. 1999b; Jiang and Altman 2002; Mitchell 
et al. 2003). The human cytoplasmic Ski complex was suggested to play a bridging function 
between an mRNA and the exosome, thereby targeting the mRNA for degradation (Araki 
et al. 2001). The 7-methyl-guanosine cap structure remaining after 3’-5’ degradation of the 
RNA-body is cleaved by the scavenger-decapping enzyme DcpS (Gu et al. 2004; Liu et al. 
2004).
1.3.3 Deadenylation independent decay
Besides the common deadenylation dependent decay, other mechanisms are known to induce 
degradation of a messenger RNA independently of deadenylation such as RNA interference 
(RNAi), and quality control mechanisms such as nonsense mediated decay, and the special 
case of endonucleolytic cleavage of mRNA. These degradation pathways are specialized 
pathways and are briefly mentioned for the sake of completeness.
1.3.3.1 Small interfering RNA (siRNA) induced degradation
The siRNA-induced degradation is thought to be a defence mechanism against viral RNA 
(Galiana-Arnoux et al. 2006; van Rij et al. 2006). Double stranded RNA is recognized 
by dicer, which contains RNAse III domains besides two RNA binding domains, and 
processed into 21 to 25nt long siRNAs (Zhang et al. 2002) which are incorporated into 
the RNAi-induced silencing complex (RISC) review in (Hutvagner 2005). RISC can now 
recognize its target sequence through base pairing, as has been proven by mutating the target 
sequence (Pillai et al. 2005). The annealing of the siRNA with the target RNA activates an 
endonuclease within the RISC called AGO2, which cuts the target RNA (Meister et al. 2004) 
that is then degraded by the exosome and Xrn1 (Orban and Izaurralde 2005). 
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1.3.3.2 RNA-quality control mechanisms
1.3.3.2.1 Nonsense mediated decay (NMD)
Nonsense mediated decay (NMD) occurs when a premature stop codon (PTC) is introduced 
within the coding region of an mRNA by transcriptional error or other means. Translation 
of this transcript would produce a truncated and potentially harmful protein, making NMD 
an important step in mRNA quality control. During the first round of translation, the exon 
junction complexes (EJC) that are deposited in the step of splicing at exon-exon junctions 
are removed by the translating ribosome. If the ribosome now encounters a stop codon 
upstream of one of these EJCs, the “surveillance complex” consisting of the upf proteins 
are recruited. In mammalian cells it is believed that the message is degraded after it is 
decapped, independent of deadenylation, by the 5’-3’ exonucleolytic pathway reviewed 
in(Weischenfeldt et al. 2005). In Drosophila, NMD is independent of the EJCs. When the 
ribosome encounters a PTC, it stalls, and recruits a yet unidentified endonuclease via the 
Upf proteins, which cleaves the RNA. The two parts of the RNA are then degraded via the 
exosome and Xrn1 (Gatfield et al. 2003; Gatfield and Izaurralde 2004).
1.3.3.2.2 Nonstop decay
The opposite situation is encountered in transcripts lacking a termination codon. In this case 
the affected cell could also produce an aberrant protein that may be harmful to the cell. This 
process, another mRNA quality control mechanism like NMD, was only recently described, 
as non-stop decay (Frischmeyer et al. 2002; Vasudevan et al. 2002). Here the ribosome 
continues to translate the poly(A)-tail, which leads to ribosome stalling and recruitment of 
the Ski complex ( Ski2p, Ski3p and Ski8p) and Ski7p. Through binding of this complex, the 
exosome is recruited directly to the message and induces its degradation (van Hoof et al. 
2002).
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1.3.3.3 Endonucleolytic cleavage
Some messenger RNAs can undergo endonucleolytic cleavage and the resulting fragments 
are subsequently degraded via both the 3’-5’ and the 5’-3’ pathway in mammalian cells. This 
has been reported in the case of c-myc and IGF-II and the transferrin receptor (Mullner and 
Kuhn 1988; Binder et al. 1994; Beelman and Parker 1995; Lemm and Ross 2002). 
1.4 Determinants of mRNA stability
Decay pathways alone however, do not provide an explanation as to, why different mRNAs 
can have half-lives ranging from 20 minutes to 24 hours. Short-lived messages mostly code 
for proto-oncogenes, proteins involved in apoptosis, cell cycle and cytokines that need to 
respond rapidly to changes in the environment, whereas long-lived messages tend to code 
for housekeeping genes, which are constitutively expressed. The half-life of a message is 
determined by cis-elements that either protects the message from degradation or renders the 
message very unstable. These elements can be found in the 5’ UTR, the coding region and 
predominantly in the 3’ UTR of a messenger RNA. We will now describe the different cis-
elements along the messenger RNA
1.4.1 Decay regulating elements in the 5’UTR
Elements responsible for the stability of the chemokine KC (Tebo et al. 2000) and the IL-
2 mRNA (Chen et al. 1998) have been identified in the 5’ UTRs of these messages. After 
activation of a T-cell, the growth factor IL-2 needs to be stabilized. One element responsible 
for this is the Jun-kinase response element (JRE) located in the 5’ UTR of the IL-2 message. 
It is bound by a complex of two proteins, nucleolin and YB-1, that are able to stabilize the 
message upon T-cells activation. 
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1.4.2 Decay regulatory elements in the coding region
The major coding region determinant (mCRD) is a decay element located in the coding 
region of c-fos, c-myc and β-tubulin. In β-tubulin, mRNA decay is coupled with translation. 
The first 13 nucleotides, which are translated, decide whether the transcript is degraded 
or translated. If sufficient levels of β-tubulin protein are present, the ribosome stalls after 
the fourth amino acid and the RNA is degraded, preventing an overproduction of tubulin 
(Gay et al. 1987; Yen et al. 1988; Gay et al. 1989). In c-fos, the mCRD consists of a long 
(320 nt) purine-rich sequence that is bound by a complex consisting of AUF1 p37, unr, the 
poly(A) binding protein (PABP), and the PABP interacting protein (Grosset et al. 2000). 
Unr was identified as the protein directly interacting with the purine-rich region and PABP, 
and is essential for CRD function. When translation is blocked, c-fos mRNA remains stable, 
but during ongoing translation, the deadenylase CCR-4 is recruited to unr and initiates the 
deadenylation of the message, inducing rapid degradation (Chang et al. 2004). In the case 
of the c-myc mRNA, the CRD is located in the exons 2 and 3 (Yeilding and Lee 1997). 
This sequence is bound by the CRD-binding protein, which protects the message from 
endonucleolytic cleavage (Prokipcak et al. 1994; Lemm and Ross 2002). There is also 
physiological evidence for the importance of this process during myoblast differentiation, 
where c-myc must be down regulated. The current decay-model is that the ribosome pauses 
in the absence of the CRD-binding protein, leaving the cleavage site unprotected, which can 
therefore be cleaved by an endonuclease (Bergstrom et al. 2006).
1.4.3 Decay elements in the 3’UTR
1.4.3.1 The iron response element
The iron response element (IRE) was the first element discovered regulating mRNA decay. It 
was defined as a loop structure (23 to 27 bases long) located in the 3’ UTR of the transferrin 
receptor (TfR) and in the 5’ UTR of ferritin where it controls translation. Both proteins 
are involved in regulating the iron level in the cell. At low iron levels, two iron dependent 
regulatory proteins, IRP1 and 2, bind to the IRE of the TfR-mRNA, stabilizing the message, 
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which leads to production of TfR and subsequently to iron uptake. At the same time, IRP1 
and 2 bind to the ferritin 5’UTR, where they prevent translation and with that any further 
iron sequestration by ferritin. If sufficient iron levels are present again, iron binds to the IRPs 
and inactivates them, leading to reduced iron uptake and increased iron storage reviewed in 
(Rouault and Klausner 1997). 
1.4.3.2 Stem loop structures
Another decay promoting element was found in the 3’UTR of the insulin growth factor-II 
(IGF-II) mRNA, which consisted of a stem loop. By an as yet unknown mechanism, the 
RNA is cleaved by an endonuclease and is subsequently degraded (Scheper et al. 1995). A 
stem-loop binding protein has been identified, but its role in the degradation of this mRNA 
could not be proven (Scheper et al. 1996; van Dijk et al. 2001).
A special case is histone H3 mRNA, an atypical RNA polymerase II transcript, which is 
not capped or polyadenylated. It also contains a short stem loop at its 3’ end (Pandey and 
Marzluff 1987), which was implicated in cell cycle driven decay of the histone H3 message 
mediated by a stem loop binding protein (Whitfield et al. 2000). In an in vitro system, it 
could be shown that the histone H3 protein promotes its own decay but not the decay of 
control RNAs (Peltz and Ross 1987). It was reported that the histone H3 mRNA degradation 
is promoted by the exonuclease 3’hExo which specifically interacts with the histone H3 
stem-loop (Yang et al. 2006).
1.4.3.3 The AU-rich element
The best-studied cis-element responsible for degradation is the AU-rich element (ARE), 
which is located in the 3’UTR of about 5% to 8% of all messenger RNAs (Bakheet et al. 
2001; Bakheet et al. 2006). When this element is inserted in the 3’ UTR of an α-globin 
reporter, the normally very stable α-globin message (half-life of more than 12h) becomes 
very unstable and is degraded in about half an hour (Shaw and Kamen 1986) illustrating 
nicely the power of this element. As the name AU-rich element already implies, the 
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sequences responsible for this rapid decay are rich in adenosine and uracil residues and are 
divided into three different subclasses. Classes I and II contain AUUUA pentamers, which 
can overlap to form AUUUAUUUA nonamers and are frequently found to be in an U-rich 
context (Chen and Shyu 1995). Class III AREs do not contain regular pentamers, but are 
generally U-rich (Peng et al. 1996). The different classes are distinguished by sequence 
criteria and do not necessarily reflect functional differences, as some ARE binding proteins, 
like HuR and KSRP, can bind to all three classes (Wein et al. 2003; Gherzi et al. 2004; 
Lopez de Silanes et al. 2004b). The functional differences and protein specificities of AU-
rich elements in different mRNAs seem to be influenced by sequences surrounding the ARE 
(Brewer et al. 2004; Winzen et al. 2004), and by the conformation of the AU-rich sequence 
itself (Fialcowitz et al. 2005). 
ARE-function is mediated through binding of specific proteins. Under normal conditions, 
decapping, deadenylation and exosomal degradation of the mRNA body are promoted by the 
ARE (Shyu et al. 1991; Xu et al. 1997; Gao et al. 2000; Chen et al. 2001; Mukherjee et al. 
2002; Stoecklin et al. 2006). Different stimuli can abolish the rapid degradation of a message 
caused by an ARE. Over expression of the ras oncogene stabilizes ARE containing messages 
(Schmidlin et al. 2004), and deregulation of ARE mediated turnover can also contribute 
to oncogenic transformation (Nair et al. 1989; Marderosian et al. 2006). Stabilization of 
messages through the ARE also occurs under physiological conditions, such as T-cell 
activation (Lindstein et al. 1989) or, when mast cells respond to allergens (Wodnar-Filipowicz 
and Moroni 1990), which leads then to the production of cytokines relevant for the immune 
response, many of which are encoded by ARE-containing transcripts. Furthermore, the 
knockout of the TNFα-ARE leads to the overproduction of TNFα be increasing the mRNA 
half-life to 6 hours and causes rheumatoid arthritis (Kontoyiannis et al. 1999). It has been 
reported that the ARE not only controls the stability of a message, but also the translation 
of the encoded protein (Kontoyiannis et al. 1999; Piecyk et al. 2000). These various ARE-
induced effects are mediated by ARE binding proteins (AUBPs) and will be discussed later 
in the introduction. 
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1.4.3.4 The constitutive decay element (CDE)
The constitutive decay element, the focus of study of this thesis, was recently discovered in 
our laboratory. It is unique to the TNFα 3’ UTR, and its sequence, which may form a stem 
loop, is highly conserved in mammals. Insertion of the CDE in a heterogeneous reporter 
causes rapid degradation of the reporter construct. When point mutations are inserted into 
the putative stem-loop region, the reporter decay is abrogated. However complementary 
mutations are not sufficient to restore decay activity, indicating that the actual sequence of 
this region is also important. Furthermore it was shown that, unlike the ARE, the CDE is 
insensitive to stabilizing signals like LPS, TPA, ionomycin, and transfection of activated 
ras and MEKK6, hence the name constitutive decay element. This element appears to be 
essential in order to tightly control the production of TNFα (Stoecklin et al. 2003).
1.4.3.5 Stabilizing elements
Apart from destabilizing elements, stabilizing elements have been identified in α- and β- 
globin. The α- and β-globin proteins build the haemoglobin molecules in red blood cells, 
and have to be produced for the entire lifetime of these denucleated cells, and therefore their 
mRNA has to be extremely stable. The α-globin mRNA contains a pyrimidine-rich element 
in its 3’ UTR, which is bound by the α-complex consisting of members of the αCP/hnRNP-
E family and AUF1 (Wang et al. 1995c; Kiledjian et al. 1997). This complex interacts with 
the poly(A) binding protein to increase its binding efficiency to the α-globin poly(A)-tail, 
which is now protected from deadenylation (Wang et al. 1999; Wang and Kiledjian 2000c). 
The situation is similar in the case of β-globin. Here the element comprises of a half-stem, 
which needs to be opened by nucleolin in order to facilitate αCP binding and through this, 
protection from deadenylation (Jiang et al. 2006).
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1.5 Protein factors involved in mRNA stability
As stated above, the ARE can target mRNA for rapid degradation. This cis-element is 
recognized by specific trans-acting factors that can induce rapid deadenylation, decapping 
and decay of the main RNA body. Another group of AUBPs can stabilize the ARE when a 
particular message needs to be expressed, usually after a stimulus, or during the cell cycle. A 
third group of AUBPs acts by controlling translation.
1.5.1 Destabilizing AUBPs
1.5.1.1 The Tis11/Zfp36 family
Tristetraprolin (TTP) is the founder member of a family of decay promoting proteins, 
although they possess no intrinsic nuclease activity. Four family members are known so far 
in mammals, TTP (Tis11, Zfp36p), butyrate response factor 1 (BRF1/Zfp36L1), butyrate 
response factor 2 (BRF2/Zfp36L2), and zinc finger protein 36 like 3 (Zfp36L3). The 
common feature of these four proteins is the possession of two unusual C-X
8
-C-X
5
-C-X
3
-H 
zinc finger motifs that are preceded by the highly conserved YKTEL sequence (Varnum et 
al. 1991; Amann et al. 2003; Michel et al. 2003; Hudson et al. 2004; Blackshear et al. 2005). 
Homologous proteins are also found in yeast, frog and fish (Thompson et al. 1996; De et al. 
1999).
1.5.1.1.1 Tristetraprolin (TTP/Tis11/Zfp36p/NUP475/GOS24)
TTP was simultaneously cloned by three different groups using independent approaches 
that uncovered different aspects of TTP expression. A partial cDNA sequence was found 
in a screen identifying TPA responsive genes (Varnum et al. 1989), it was also identified 
as a serum responsive gene in the nucleus (nuclear protein 475 (NUP475)) (DuBois et al. 
1990), and finally as an early response protein induced by insulin. A characteristic proline-
proline-proline-proline-glycine sequence, which is repeated three times in the protein, led 
to its being called tristetraprolin (TTP) (Lai et al. 1990). Consequently it was found to be 
inducible by other means for example with EGF, LPS and other growth stimulatory signals 
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(Carballo et al. 1998; Fairhurst et al. 2003). No function to the protein could be assigned 
to the protein until the generation of TTP knockout mice. Homozygous mice are viable, 
and apparently normal, but after a few months they begin to loose weight, and develop 
myeloid hyperplasia, polyartricular erosive arthritis, dermatitis, conjunctivitis, alopecia and 
autoimmunity (Taylor et al. 1996). This phenotype was similar to one induced by chronic 
application of the cytokine TNFα (Keffer et al. 1991), and could be completely suppressed 
by treatment with neutralizing TNFα antibodies, concluding that TTP knockout induces 
TNFα over expression (Taylor et al. 1996). Later it became clear that the knock out of TTP 
causes an increased stability of the TNFα and GMCSF mRNA. It is also involved in the 
regulation of interleukin 2 (Ogilvie et al. 2005), and the inducible nitric oxide synthetase 
(iNOS) (Linker et al. 2005). Other TTP binding mRNAs were identified by comparing 
RNA-immunoprecipitation followed by expression profiling of TTP-/- cells to the wild type. 
250 transcripts were stabilized under knock out conditions, of which 23 carried AU-rich 
elements (Lai et al. 2006).
Mechanistically, TTP binds the AU-rich element via its two zinc finger domains (Lai et al. 
1999) and thereby mediates degradation of the message (Carballo et al. 1998), and mutations 
in the zinc fingers abrogate ARE binding and decay (Lai et al. 2000). As TTP has no nuclease 
activity, it must be able to recruit the degradation machinery as was demonstrated by tethering 
experiments with TTP was fused to the MS2 protein (Lykke-Andersen and Wagner 2005). It 
could be shown that the N terminal portion of TTP interacts with and activates the decapping 
machinery (Fenger-Gron et al. 2005), deadenylases, and the exosome, thereby causing rapid 
degradation (Chen et al. 2001; Lykke-Andersen and Wagner 2005; Hau et al. 2006). 
TTP activity is negatively regulated by external signals leading to phosphorylation of the 
serines 52 and 178 by MK2 (Stoecklin et al. 2004; Hitti et al. 2006). Inhibition of the p38 
pathway leads to a relocalization from the cytoplasm to the nucleus. Furthermore, this 
phosphorylation causes the entry of TTP into stress granules by interaction with 14-3-3, 
and its decay promoting activity is reported to be inhibited (Stoecklin et al. 2004). This 
seems to be a controversial point, because another group did not find an influence of the p38 
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signalling-pathway on TTP function (Rigby et al. 2005). In addition it was also found that 
phosphorylation of TTP on these two sites causes stabilization of the protein (Brook et al. 
2006). 
1.5.1.1.2 Butyrate response factor 1 (BRF1/TIS11b/Zfp36L1/Berg36/ERF1/cMG1)
Butyrate response factor 1 (BRF1) was discovered in rat intestinal epithelial cells in early 
response after stimulation with the epidermal growth factor (EGF) (Gomperts et al. 1990). 
The human homologue was cloned later (Bustin and McKay 1999), and its expression can 
be induced by insulin, insulin-like growth factor 1 (IGF-1) (Corps and Brown 1995) and 
adrenocorticotropin (ACTH) (Chinn et al. 2002), and repressed by butyrate (Maclean et al. 
1998). The function of BRF1 has recently been discovered by a genetic screen (Stoecklin 
et al. 2002). Here a GFP reporter was fused to the IL-3 3’UTR, which contains an ARE 
and renders the reporter unstable, and introduced into human HT1080 fibroblast cells. By 
treating these cells with a frame shift mutagen and selection for high GFP expression a cell 
line was isolated, slow C, in which the reporter transcript was stabilized. By reintroduction 
of a cDNA library from the parental cell line, BRF1 was cloned as a gene capable of 
restoring rapid mRNA decay. It was confirmed that in slowC cells, both alleles of BRF1 
contained frame-shift mutations. BRF1 binds like TTP to AU-rich sequences via its zinc 
fingers and mutation of these leads to abrogation of degradation due to loss of RNA binding 
(Stoecklin et al. 2002). The mechanism by which BRF1 mediates decay is also similar to 
that of TTP via recruitment of deadenylases, the decapping machinery and the exosome to 
the targeted RNA (Lykke-Andersen and Wagner 2005). One of the BRF1 target genes was 
published to be VEGF (Ciais et al. 2004), but in our group, we have seen no effect of BRF1 
on the stability of this putative target that could be confirmed using the BRF1-/- cell line. 
Nevertheless VEGF expression is increased in a BRF1-/- context (Raineri, unpublished data), 
but probably by an unknown mechanism unrelated to mRNA degradation. As with TTP, 
BRF1 is also responsive to extra cellular stimuli. Activation of the PI3 kinase-pathway by 
insulin leads to the phosphorylation of BRF1 on S92 and S203 by PKB/Akt, which results 
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in BRF1-14-3-3 binding, and inactivation of the BRF1 decay promoting activity. Similar to 
TTP, BRF1 protein is stabilized by the phosphorylation of these two sites (Schmidlin et al. 
2004; Benjamin et al. 2006).
1.5.1.1.3 Butyrate response factor 2 (BRF2/Tis11d/Zfp36L2/ERF2)
Mouse BRF2 was discovered as the third member of the zinc finger protein 36 family 
(Varnum et al. 1991), and the human homologue a few years later (Nie et al. 1995). As with 
the other family members, it contains the highly conserved zinc finger region and is most 
identical to BRF1, with the exception of a unique extension at the 5’ terminus. Therefore it 
was no surprise that BRF2 is also able to induce ARE-mediated degradation, as shown with 
the TNFα-ARE (Lai et al. 2000). Recently, the structure of the BRF2 zinc finger domain has 
been resolved by NMR in complex with an UUAUUUAUU nonamer, showing that each 
zinc finger interacts with an UUAU sequence (Hudson et al. 2004). It is suspected, because 
of the high level of identity between the zinc fingers, that the binding of TTP and BRF1 is 
similar although this remains to be proven. To elucidate BRF2 function, a knock out mouse 
has been produced that lacks the N-terminal 29 amino acids. The offspring were viable, in 
contrast to the BRF1 knock out mouse, and the only phenotype seen was female infertility. 
Transplantation of wild type ovaries was able to restore fertility (Ramos et al. 2004).
1.5.1.1.4 Zinc finger protein 36-like 3
This protein was only recently discovered on the X-chromosome in mouse by a database 
search for the tandem zinc finger motif. A homologue could be detected in rat, but not in 
humans. It is expressed in trophoblastic placenta and extra embryonic tissue, and GFP-
Zfp36L3 fusion proteins could only be detected in cytoplasm. Like the other members, it 
is able to bind AU-rich elements and was shown to promote degradation of ARE-bearing 
messages when overexpressed. It was also able to promote degradation in vitro (Blackshear 
et al. 2005).
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1.5.1.2 K homology-type splicing regulatory protein (KSRP/FBP2)
K homology-type splicing regulatory protein (KSRP) was originally identified in neurons 
involved in c-src splicing (Min et al. 1997). It contains four KH-type RNA binding motifs 
(for K-homology), which are essential for KH-protein driven differentiation in flies, worms 
and mammals (Adinolfi et al. 1999). KSRP was found to be ubiquitously expressed, and 
could be shown to interact with the TNFα, c-fos, pitx2 and IL-8 -AREs (Chen et al. 2001; 
Briata et al. 2003; Gherzi et al. 2004; Suswam et al. 2005). It was also implicated to play 
a role in the myoblast to myocyte transition by interacting with the AREs of myogenic 
transcripts (Briata et al. 2005), and in the regulation of human iNOS, together with TTP 
(Linker et al. 2005). KSRP copurified with the exosome and it is speculated, that KSRP 
might bridge the ARE-containing RNA and the exosome, and thus induce degradation (Chen 
et al. 2001). Further studies revealed that KSRP associates with the deadenylase PARN, the 
decapping enzyme Dcp2, and the exosomal protein Rrp4 via its KH2 domain (Gherzi et al. 
2004; Chou et al. 2006). Recently it was found that over expression of KSRP in the BRF1-/- 
slow C cell line is able to restore ARE-mRNA degradation. KSRP activity is also regulated 
by phosphorylation via the p38 pathway, which leads to the inhibition of mRNA decay 
activity (Briata et al. 2005).
1.5.1.3 Polymyositis-scleroderma antigen (PM-Scl 75)
An ARE-binding protein that was found to be a core component of the exosome is the 
polymyositis-scleroderma antigen (PM-Scl75) (Mukherjee et al. 2002). It is believed that 
this interaction facilitates ARE-dependent decay. It could be shown in vitro that a 266 amino 
acid long region from the RNAse PH domain of PM-Scl 75 is responsible for the AU-
specific binding. Furthermore, other components of the exosome such as OIP and Rrp41p 
are implicated in AU-rich RNA binding (Andersonet al. 2006). However the issue of specific 
AU-rich element binding of PM-Scl 75 is not generally accepted yet.
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1.5.1.4 CUG binding protein 2 (NAPOR2/ETR-3/BrunoL3)
CUG binding protein 2 (CUGBP2) belongs to the CELF (CUGBP-Etr-3-like factor) family, 
which is thought to be involved in alternative splicing and RNA editing (Ladd et al. 2001), 
and was first identified as a protein binding CUG-repeats in myotonic dystrophy (Lu et 
al. 1999). It contains three RNA recognition motives (RRMs/RBPs), of which two are 
structured in a tandem repeat (Choi et al. 1998). This protein was shown to interact with 
the ARE of cyclooxygenase 2 (COX-2), where it stabilizes the message, but paradoxically 
inhibits translation (Mukhopadhyay et al. 2003). 
1.5.1.5 RHAU
The RNA helicase RHAU was found as a protein binding the AU-rich element of the urokinase 
plasminogen activator (uPA). The alternative splice form of this protein is localized to the 
cytoplasm and affects the degradation of the uPA-ARE, for which the ATPase activity of the 
helicase is needed. RHAU was also found to interact directly with PARN, and the exosome, 
which then promotes decay (Tran et al. 2004). 
1.5.2 Stabilizing AU-binding proteins
1.5.2.1 HuR (HuA)
HuR was originally identified in Drosophila melanogaster by a genetic screen in the embryonic 
lethal abnormal vision (elav) locus and is essential for neuronal development (Campos et al. 
1985). It is a member of the ELAV family of RNA binding proteins, which contain three 
RRMs. Several mRNA targets could be identified for this protein, including IL-3, c-fos and 
TNFα amongst others by UV-crosslinking assays, bandshift, and RNA-immunoprecipitations 
followed by analysis on a genome array (Ma et al. 1996; Dean et al. 2001; Lal et al. 2004; 
Lopez de Silanes et al. 2004a). Unlike the other AUPBs discussed so far, HuR stabilizes 
ARE-containing RNAs when overexpressed (Fan and Steitz 1998b; Peng et al. 1998; 
Chen et al. 2001; Ming et al. 2001). This is supported by HuR knock down experiments 
by anti-sense RNA or RNAi techniques, which led to a destabilization of the messenger 
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RNAs tested (Wang et al. 2000a; Wang et al. 2000b; Raineri et al. 2004). Computational 
analysis indicates that HuR does not necessarily bind to classic AREs, but generally to U-
rich regions (Lopez de Silanes et al. 2004b), and protects the message from degradation. 
HuR possesses three RRMs, where RRM 1 and 2 are in tandem. Deletion of the third RRM, 
which was suggested to bind the poly(A)-tail (Ma et al. 1997), abrogates stabilization of an 
ARE-containing message despite over expression (Fan and Steitz 1998b). The stabilization 
of certain messages, like the tumor suppressor p21, RhoB (Wang et al. 2000b; Westmark et 
al. 2005), or CD83 (Prechtel et al. 2006) was correlated to HuR presence in the cytoplasm, 
which is normally localized to the nucleus. The nuclear localization is caused by a nuclear 
localization signal (NLS) situated between RRMs two and three (Fan and Steitz 1998a), and 
it can be exported into the cytoplasm via the export protein CRM-1. This export is induced 
by various stimuli like heat shock (Gallouzi et al. 2003), UV-irradiation (Wang et al. 2000a), 
and other signals, which subsequently lead to the stabilization of ARE containing messages. 
It is believed that HuR is co-exported with the message thereby increasing its stability (Fan 
and Steitz 1998a; Fan and Steitz 1998b). A protein that co-purifies with HuR is the poly(A)-
binding protein (PABP) and it is suggested that HuR stabilizes the message by increasing 
the affinity of PABP for the poly(A)-tail, and so protects the message from degradation 
(Nagaoka et al. 2006). Several other proteins have been found to associate with HuR, namely 
SETα/β (von Lindern et al. 1992), pp32 (Malek et al. 1990), APRIL (Mencinger et al. 1998), 
where SETα/β and pp32 were previously identified to inhibit the phosphates PP2A (Li et 
al. 1996; Saito et al. 1999), which may play a role in the regulation of ARE-mRNA decay. 
Furthermore pp32 and APRIL were found to interact with CRM-1. It is speculated that this 
interaction may modulate the export of HuR (Gallouzi and Steitz 2001).
HuR over expression was also implicated to play a role in tumorigenesis in colon cancer 
(Dixon et al. 2001), and tumors of the central nervous system (Nabors et al. 2001). In 
addition, HuR is implicated in muscle differentiation by stabilizing myogenin and MyoD, 
two important transcription factors involved in myogenesis when it is overexpressed 
(Figueroa et al. 2003), and it inhibits muscle differentiation when downregulated by RNAi 
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(van der Giessen et al. 2003). HuR also seems to play a role in the muscle wasting disease 
cachexia, where it regulates induced nitric oxide synthethase in an AMPK dependent manner 
(Di Marco et al. 2005). By a RNA-IP approach, the specific targets of HuR and AUF1 have 
been identified in HeLa cells (Lal et al. 2004). Besides its function in RNA stabilization, 
HuR was implicated in translational de-repression induced by micro RNAs on CAT-1 
mRNA. In nonstarved HuH7 cells, the CAT-1 mRNA localizes to P-bodies (PB) though 
the action of microRNA miR-122. When anti-sense miR-122 is transfected, or the cells are 
deprived of amino acids, CAT-1 mRNA relocalizes from the PBs and is efficiently translated. 
This relocalization was committed by HuR binding the CAT-region D (Bhattacharyya et al. 
2006).
1.5.2.2 AU-binding factor-1 (AUF1/hnRNP D)
AUF1 was originally identified as a promoter of ARE-mediated decay (Brewer 1991). It 
exists in four isoforms that are generated by alternative splicing of exon 2 and/or exon 7. The 
resulting isoforms are p37 (lacking exon 2 and 7), p40 containing exon 2, p42 containing 
exon 7, and p45, which possesses both alternative exons. The exon 7 plays a role in 
localization, so that the isoforms p42 and p45 are mainly located in the nucleus, whereas p37 
and p40 are mainly in the cytoplasm. The isoforms lacking exon 7 are readily ubiquitinated 
and degraded by the proteasome, in contrast to p42 and p45 (Laroia and Schneider 2002). 
The absence of exon 2 has been associated with high ARE-binding affinity (DeMaria et al. 
1997), and over expression of p37 and p42, lacking exon 2, antagonizes stabilization and 
leads to hemin-induced differentiation of K562 cells into erythroblasts (Loflin et al. 1999). 
When overexpressed, AUF1 also leads to increased degradation of ARE bearing messages 
in smooth muscle cells (Pende et al. 1996), monocytes (Sirenko et al. 1997) and peripheral 
blood mononuclear cells (Buzby et al. 1996; Buzby et al. 1999), however over expression 
of all four isoforms in 3T3 cells stabilizes ARE-messages (Xu et al. 2001), so the precise 
role of AUF1 in ARE-mediated decay is still not clear. Several models have been proposed 
where some isoforms cause stabilization, while the others cause degradation, depending on 
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the particular cell line and the type of ARE under investigation (Xu et al. 2001; Raineri et al. 
2004). In contrast to HuR, AUF1 seems to induce stability by maintaining the conformation 
of its target RNA in a condensed conformation. This process is dependent upon the 
phosphorylation state of AUF1 S83 and S87 (Wilson et al. 2003a; Wilson et al. 2003b). 
AUF1 knockout mice have only recently been described. When these mice are challenged 
with endotoxins they display symptoms of severe toxic shock syndrome like vascular 
hemorrhage, intravascular coagulation and high mortality. This phenotype could be rescued 
by application of neutralizing antibodies against TNFα and interleukin 1 beta (IL-1β). Thus 
AUF1 plays a major role in the inflammatory response (Lu et al. 2006). Further targets for 
AUF1 in HeLa cells have also been recently identified by RNA immunoprecipitation (Lal et 
al. 2004). 
Besides its function in ARE-mediated degradation, it is a part of the α-complex protecting 
the α-globin message from degradation (Kiledjian et al. 1997), and it also appears to play a 
role in the c-fos CRD driven degradation (Grosset et al. 2000). Besides RNA stability, other 
functions have emerged for AUF1, and it was reported to be involved in telomere maintenance 
(Eversole and Maizels 2000), transcriptional activation in EBV (Fuentes-Panana et al. 2000) 
and it may also regulate translation of the IL-6 message (Paschoud et al. 2006).
1.5.3 Translation regulatory AUBPs
1.5.3.1 T-cell intracellular antigen-1 (TIA-1)
The T-cell intracellular antigen-1 (TIA-1) functions as a regulator of translation and splicing 
(Del Gatto-Konczak et al. 2000). It possesses three RRMs and a G-rich region at the C-
terminus. The RRM2 is capable of binding to U-rich sequences, whereas RRM3 seems to 
have no sequence specificity. RRM1 does not appear to bind to RNA at all (Dember et al. 
1996). The C-terminal domain is related to the prion protein and can induce self-assembly 
into stress granules (Gilks et al. 2004). TIA-1 can specifically interact with the COX2- and 
TNFα-ARE via its RRMs (Piecyk et al. 2000; Dixon et al. 2003; Cok et al. 2004), and 
current reports state that it also plays together with HuR a role in regulating cytochrome c 
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expression (Kawai et al. 2006). Recently a number of target RNAs have been identified by 
RNA-immunoprecipitation. In silico analysis identified a consensus sequence and messages 
bearing this sequence in its 3’UTR undergo translational control (Lopez de Silanes et al. 
2005). TIA-1 knock out mice have 50% embryonic lethality. In macrophages derived from 
TIA-1 knock out mice, elevated levels of TNFα protein was produced, but the amounts 
and half-life of the message were unchanged compared to macrophages derived from wild 
type mice. This indicates that TIA-1 controls TNFα production by inhibition of translation, 
as more TNFα mRNA was associated with polysomes in TIA-1-/- macrophages (Piecyk et 
al. 2000). This effect seems to be specific for TNFα, as GMCSF or interferon γ translation 
was unaffected. TIA-1 is also a nucleo-cytoplasmic shuttling protein, and is transported to 
the cytoplasm under stress conditions, where it organizes in stress granules (Kedersha et al. 
1999). Whether this effect is physiological or pathological is not clear, because the stresses 
used, like arsenite or FCCP, will lead inevitably to the death of the cells. For review see 
(Kedersha and Anderson 2002).
1.5.3.2 TIA-1 related protein (TIAR)
TIAR is very similar to TIA-1 with respect to protein organization and translational regulation. 
It also consists of three RRMs and the prion-protein domain (Dember et al. 1996). It is also 
involved in translation control as well as in splicing (Le Guiner et al. 2001) and organization 
into stress granules as TIA-1 (Kedersha et al. 1999). mRNAs shown to be translationally 
controlled by TIAR are the iNOS (Fechir et al. 2005) and TNFα mRNA (Gueydan et 
al. 1999). Recently a large number of mRNA-targets for TIAR have been identified by 
RNA-immunoprecipitation, which include many proteins involved in translation (Mazan-
Mamczarz et al. 2006). The mechanism by which TIA-1 and TIAR inhibit translation are yet 
unknown. In contrast to TIA-1, knockout mice of TIAR are 100% embryonic lethal (Beck 
et al. 1998).
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1.6 Regulation of TNFα
1.6.1 Why did we choose TNFα mRNA as our model system?
Tumor necrosis factor alpha (TNFα) is a major mediator of inflammation, which is induced 
early after injury and infection. This factor is mainly produced by macrophages and T cells in 
a secreted or membrane bound form in response to various stimuli. Mice deficient in TNFα 
lack splenic primary B cell follicles and are unable to form organized follicular dentritic cell 
networks and germinal centers, implicating its relevance in the maturation of the humoral 
immune response (Pasparakis et al. 1996). Under physiological conditions, TNFα is released 
locally and transiently at the site of infection, whereas constitutive expression is pathological 
and may lead to rheumatoid arthritis, and other autoimmune disease (Keffer et al. 1991). A 
systemic release of TNFα, induced by stimulation of macrophages with lipopolysaccharide 
from the cell wall of gram-negative bacteria, mediates septic shock (Tracey and Cerami 
1994; Karima et al. 1999), but not so in TNFα deficient mice.
1.6.2 Induction of TNFα expression
TNFα is regulated at virtually every step of its maturation process in order to ensure that 
only limited amounts of this toxic cytokine are produced. TNFα production is induced in 
response to LPS binding to the Toll-like receptor-4 receptor (TLR-4) (Poltorak et al. 1998; 
Hoshino et al. 1999) (Fig. 3). First, LPS complexes with the soluble LPS-binding protein 
(LBP) that circulates in the bloodstream (Schumann et al. 1990). The interaction of the LPS-
LBP complex with TLR-4 is mediated by CD14 (Viriyakosol and Kirkland 1996; Muroi et 
al. 2002) and finally causes activation of NF-κB and other transcription factors (Collart et al. 
1990; Trede et al. 1995; Yang et al. 1998; Myokai et al. 1999; Steer et al. 2000). Important 
signalling molecules are MyD88, which directly interacts with TLR-4 (Wesche et al. 1997), 
and IRAK4 (Li et al. 2002), a signalling molecule directly downstream of MyD88. MyD88-/- 
and IRAK 4-/- mice are resistant to LPS induced toxicity although NF-κB can still be activated 
via a MyD88 independent pathway (Kawai et al. 1999; Takeuchi et al. 2000; Horng et al. 
2001; Suzuki et al. 2002; Fitzgerald et al. 2003). IRAK4 then activates IRAK1, and through 
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this TRAF6 (Cao et al. 1996). Activated TRAF6 leads to an activation of MEK kinase and 
the IKK regulatory subunit NEMO, which result in NF-κB and c-jun promotion of TNFα 
mRNA transcription (Collart et al. 1990; Trede et al. 1995; Yang et al. 1998; Myokai et al. 
1999; Steer et al. 2000). Furthermore MKK3 activates the p38-MK2 pathway which leads, 
as described before, to inactivation of TTP and TNFα mRNA stabilisation (Stoecklin et al. 
2004; Hitti et al. 2006). This is reviewed in (Palsson-McDermott and O’Neill 2004).
FIG. 3. Simplified model of the TOLL 4 receptor signalling. LPS is bound by LPB outside of the cell, and 
brought into contact with the TOLL4 receptor via CD14. The extrinsic signal is then transduced via MyD88, 
IRAK4, IRAK1 and TRAF6 to the TAK/TAB complex. This complex leads on one hand via IKK to the release 
of transcription NFκB into the nucleus and transcription of the TNFα mRNA, and on the other hand to the 
activation of the p38 pathway, which inhibits via MK2 the degradation of the TNFα mRNA by sequestering 
TTP.
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1.6.3 Post-transcriptional regulation of TNFα
The TNFα mRNA contains in its 3’ untranslated region (UTR) an AU-rich element (ARE) that 
interacts with various ARE-binding proteins that regulate its nuclear-cytoplasmic transport, 
decay activity and translation efficiency (Shyu and Wilkinson 2000; Wilusz et al. 2001). 
Tpl2-deficient mice retain TNFα in the nucleus upon LPS induction (Dumitru et al. 2000), 
indicating a deficiency in TNFα mRNA transport. To guarantee only a transient production 
of TNFα, its mRNA decay rate is tightly controlled. In lymphocytes stimulated with CD3 
and CD28, the normally very labile TNFα mRNA becomes markedly stabilized (Lindstein 
et al. 1989), whereas in macrophages the issue is controversial. In reporter assays, where 
the TNFα coding sequence was replaced by the chloramphenicol acetyl transferase gene, no 
changes in reporter stability could be detected. The reporter RNA remained quite stable upon 
LPS treatment, but translation of CAT seemed to be increased (Han et al. 1990; Raabe et al. 
1998). Subsequently the TNFα mRNA was explored by the same group. Here they found 
again, that after LPS induction, the CAT-reporter was quite stable, but endogenous TNFα-
mRNA was rapidly degraded (Han et al. 1991; Brook et al. 2000), which could be supported 
by findings in our group. We could demonstrate that TNFα mRNA levels are induced by LPS 
over 6 hours and declines again thereafter, but the message remained unstable, whereas an 
isolated TNFα-ARE-sequence fused to a β-globin reporter was stabilized (Stoecklin et al. 
2003). In contrast it was reported, that the TNFα mRNA is stabilized upon LPS treatment, 
and that the inhibition of the p38 MAP kinase pathway leads to degradation of TNFα 
mRNA, which was also confirmed in MK2 knockout mice (Han et al. 1991; Brook et al. 
2000; Stoecklin et al. 2004; Hitti et al. 2006). There was even one group, which found that 
the TNFα-mRNA is stable independently of LPS stimulation (Han et al. 1990; Raabe et al. 
1998). 
TNFα ARE mediated decay in macrophages is mediated by TTP, which binds directly to 
the AU-rich sequence, and recruits factors mediating deadenylation, decapping and mRNA 
body decay (Chen and Shyu 1995; Stoecklin et al. 2001; Lykke-Andersen and Wagner 2005). 
Macrophages isolated from TTP-deficient mice produced high amounts of TNFα due to an 
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increase of its mRNA half-life (Carballo et al. 1998). Furthermore TTP was demonstrated to 
be phosphorylated and thereby inactivated by the p38 pathway (Stoecklin et al. 2004; Hitti et 
al. 2006), which is in turn activated via the TLR-4 signalling pathway leading to an increased 
stability of the TNFα message, as shown in MK2-deficient mice. Another factor reported to 
influence TNFα expression is AUF1, which seems to induce degradation of this message 
demonstrated in AUF1 knockout mice (Lu et al. 2006). When the TNFα-ARE is vacated by 
TTP and AUF1, HuR was found to associate with this ARE and cause stabilization of the 
TNFα message (Dean et al. 2001). Besides the ARE, the constitutive decay element (CDE) is 
located in the TNFα 3’UTR (Stoecklin et al. 2003). The CDE was discovered in slowC cells, 
which are unable to promote ARE dependent decay, but could rapidly degrade a reporter 
containing the entire TNFα 3’UTR independent of the AU-rich element. The CDE is located 
directly downstream of the TNFα-ARE, promotes constitutive degradation of the TNFα 
message, and is unresponsive to stabilizing agents such as LPS or phorbol esters (Stoecklin 
et al. 2003). 
In addition to mRNA decay, TNF-α is regulated on the level of translation by TIA-1 which 
has high affinity to the TNFα ARE. In macrophages derived from TIA-1 deficient mice, 
higher levels of TNFα were produced compared to wild type macrophages from similar 
amounts of TNFα mRNA (Piecyk et al. 2000). This process is modulated by the mitogen 
activated protein kinase-2 (MAPKAP) (Kotlyarov et al. 1999).
1.7 Aim of the project
The project is aimed at understanding the mechanisms by which the TNFα message is 
controlled. Four different points were addressed during these studies:
1.7.1 Definition of the minimal active CDE
The smallest active constitutive decay element (CDE) was found to be 40nt long. The CDE 
as previously characterized by Stoecklin et al., was 80nt long with a half-life of roughly 
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two hours. In contrast, the complete 3’UTR sequence downstream of the ARE (element II) 
only had a half-life of 45 minutes (Stoecklin, Lu et al. 2003). By deletion mutagenesis, we 
were able to reduce the size of the CDE to 40nt, and mapped it to a region 42 nucleotides 
downstream of the last AUUUA pentamer. With this deletion we also restored the rapid 
decay phenotype of t1/2 = 45 minutes observed with the element II. Mutations introduced 
into this sequence could no longer promote decay.
1.7.2 Nucleolin binds to the CDE
The next issue was to identify a protein binding to the CDE. We were able to visualize an 
UV-crosslink activity at roughly 60 kD, which was competed by the CDE, but not by an ARE 
RNA. We purified this activity with a three-step purification procedure over heparin, affinity 
and anion exchange matrix. The crosslinking protein was identified by mass spectrometry as 
the RNA-binding protein nucleolin.
1.7.3 The nucleolin-CDE interaction is specific
Band shift assays with cytoplasmic macrophage extracts revealed that only the CDE 
can supershift with nucleolin, but not any of its mutants. This could be confirmed using 
recombinant full-length nucleolin produced with the baculovirus-expression system. To 
prove that nucleolin interacts with the TNFα mRNA in vivo, RNA-immunoprecipitation 
experiments were performed. Nucleolin was only able to pull down TNFα mRNA, and no 
other message tested. 
1.7.4 Downregulation of nucleolin by RNAi slightly increased   
         GFP-CDE-reporter stability
To provide functional evidence for the nucleolin-CDE interaction, nucleolin was 
downregulated by RNAi in a cell line expressing a GFP reporter linked to the CDE. By 
FACS analysis, increased GFP fluorescence was detectable when nucleolin was knocked 
down, which correlates with a slight but significant increase in the reporter half-life from 96 
to 136 minutes.
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2. Results
2.1 Part I: Identification of the smallest active   
      constitutive decay element (CDE)
2.1.1 Definition of the constitutive decay element (CDE) by  
         deletion mapping
This study focuses on the mRNA of tumor necrosis factor alpha (TNFα), which causes toxic 
shock syndrome and the autoimmune disease rheumatoid arthritis when its expression is 
dysregulated. As previously mentioned, the expression of TNFα is regulated at many steps, 
but in this study, we concentrated on RNA stability. As stated in the introduction, TNFα 
mRNA carries two destabilizing elements in its 3’UTR leading to its rapid degradation. One 
of them is the well-characterized AU-rich element (ARE) that is bound by the destabilizing 
proteins TTP and AUF1 (Taylor et al. 1996; Lu et al. 2006), and the stabilizing protein HuR 
(Dean et al. 2001) as well as the translation repressor TIA-1 (Piecyk et al. 2000). The other 
element is the only recently discovered CDE, which was defined as an 80nt long sequence 
directly adjacent and downstream to the ARE. This study utilizes as a starting point the 
fragment K, which contains 19 extra nucleotides including an AUUUA pentamer at the 5’ 
end of fragment KΔAU. These extra nucleotides do not have an influence on decay kinetics 
as was shown by Stoecklin et al. (Stoecklin et al. 2003). 
To map this element more precisely, we deleted the fragment K beginning from the 5’ end to 
obtain the fragments M and O, which were then inserted downstream of a β-globin reporter 
(Fig. 4A). We assayed the decay activity of the various fragments by transient transfection 
into NIH3T3 B2A2 cells with the β-globin reporter alone (control) or carrying the various 
fragments followed by transcriptional arrest with actinomycin D (act. D) for 0, 30 and 60 
minutes. As demonstrated in a representative experiment (Fig. 4B), the β-globin control or 
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FIG. 4. Deletion mapping of the CDE within fragment K of the TNFα 3’UTR. (A) Fragments K, M, O and 
L were inserted into the 3’UTR of the β-globin reporter gene in plasmid puroMXβglobin. (B) After transient 
transfection into NIH 3T3 B2A2 cells, the stability of the reporter mRNAs was determined by actinomycin D 
(act. D) chase experiments. For each time point, cytoplasmic RNA was extracted and processed for northern 
blot analysis. Reporter RNA was detected using a radiolabelled SP6 generated probe specific for β-globin, 
and transfection efficiency and loading were controlled by rehybridizing with a probe against puromycin N-
acetyltransferase (puro) expressed by the reporter plasmid. (C) Reporter levels were quantified with Quantity 
One software and normalized against the loading control. Percentage of decay was plotted against time of a 
representative experiment. (D) The β-globin O and L reporters were stably transfected into NIH 3T3 B2A2 
cells by selection with 1μg/ml puromycin. The stability of the reporter in these cells was determined by act. D 
chase experiments and northern blot as described above.
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fragment L bearing reporter were stable, whereas the fragment K promotes decay with an 
approximate half-life of two hours. Deletion of 41nt (fragment M), or 61nt (fragment O) 
from the 5’ end led to a strong acceleration of the rate of decay, resulting in a half-life of 
approximately 45 minutes for both fragments. This corresponds to the half-life determined 
for the entire 277nt sequence downstream of the ARE, TNFα-E2 (Stoecklin et al. 2003) and 
suggests that this is the entire functional element. The 40nt long fragment O appears to be the 
minimal functional element that can still induce rapid reporter degradation, and a further 10nt 
deletion (fragment L) is sufficient to fully abolish activity. Fig. 4C shows the quantification 
of one representative experiment. Next, we stably transfected the β-globin-O and –L 
constructs into NIH3T3 B2A2 cells to see whether the stably transfected reporters behave 
the same as when transiently expressed (Fig. 4D). Here as well, the fragment O induced a 
very rapid decay with a half-life of less than 45 minutes. In this case fast deadenylation can 
be observed, which suggests, that the CDE-reporter is degraded via the 3’-5’ exonucleolytic 
pathway. 
2.1.2 Mutations in fragment O lead to loss of CDE activity
After defining fragment O as the minimal CDE, we next asked whether mutations in 
fragment O can affect its decay capability. In the CDE fragment K, which has a half-life of 
approximately two hours, decay activity was completely abolished by the introduction of a 
few point mutations (Stoecklin et al. 2003). Therefore we generated and analysed mutants 
of the CDE-fragment O by degradation assays. We cloned the sequences indicated in Fig. 
5A into the puroMXβglobin vector. The green-boxed bases indicate the nucleotides which 
were mutated, whereas the red dashed lines indicate deletions in the fragment O. In the 
mutant Om2, we replaced five of the eight uridine residues by a different nucleotide, to 
assess the importance of the U-rich stretch for CDE-mediated decay. This mutant reporter 
was completely stable in in vivo decay assays (Fig. 5B). Within Om3, we only mutated the 
first four nucleotides, to see whether the mutations introduced into the putative stem in Om2 
are responsible for the severe stabilization effect, but here too the reporter Om3 RNA was 
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completely stable. Furthermore, this mutant demonstrates the importance of the 3’ end of 
fragment O for promoting degradation, because L, from which the first six nucleotides are 
deleted, is also stable as reported by (Stoecklin et al. 2003). We were curious, if the non-
U-rich sequences in this element also have an effect on stability. We deleted a 6nt part of 
fragment O to obtain mutant Om5, or the 6nt at the 3’ end to generate Om6. Both mutants 
were very stable in vivo. These observations suggest that the sequence in fragment O is 
necessary to promote rapid degradation, and that this minimal CDE is sensitive to even slight 
changes in its sequence. 
FIG. 5. Mutational analysis of fragment O, the minimal CDE. (A) Fragment O and its mutants Om2, Om3, 
Om5, Om6 and L were inserted into the 3’UTR of the β-globin reporter gene in plasmid puroMXβglobin. 
Nucleotide changes are indicated in green and deletions by red dashed lines. (B) After transient transfection 
into NIH 3T3 B2A2 cells, the stability of the reporter mRNAs was determined by act. D chase experiments. 
Northern blot analysis was performed as described in Fig. 1. The blot was reprobed against actin as loading 
control.
Results
44
Results
45
2.2 Part II: Purification and identification of  
      nucleolin as the CDEBP
2.2.1 Detection of CDE-specific binding proteins
In contrast to the ARE, a CDE-bearing reporter is insensitive to RNA stabilizing signals 
emanating from extra-cellular stimuli such as phorbol esters, ionomycin, lipopolysaccharide 
(LPS), or over-expression of activated ras and activated MEK6 kinase (Stoecklin et al. 
2003). This distinct behaviour suggests a different mechanism by which the CDE-bearing 
message is degraded. To elucidate the mechanism underlying CDE mediated decay, we tried 
to identify proteins specifically binding to the CDE-fragment K by UV-crosslinking assays. 
We incubated LPS-stimulated Raw 264.7 macrophage cytoplasmic extracts with an in vitro 
transcribed fragment of the CDE-K probe incorporating the crosslinking agent 4-thio-UTP 
and [α32P]-ATP. We competed the radioactive probe with increasing amounts of unlabeled 
K- or unlabeled TNFα ARE- transcripts to score for the specificity of the K-probe protein 
interactions. The CDE-binding proteins were then crosslinked by ultraviolet radiation, and 
the complexes were analyzed by 7.5 to 15% SDS-PAGE and phosphorimaging. We could 
identify three activities binding the CDE at 200kD (complex 3), 90kD (complex 2) and 
60kD (complex 1) (Fig. 6A). Only the 60kD band was sensitive to specific competition 
by the unlabeled probe K and not the ARE, indicating that complex 1 binds specifically to 
the CDE-K probe, whereas complex 2 and 3 are unspecific. As an alternative approach to 
discover specific CDE binding proteins, we performed electrophoretic mobility shift assays 
(EMSAs) und used here the shorter probe CDE-O and probes of the non-functional mutants 
of O identified above, which were incubated with LPS-stimulated Raw 264.7 macrophage 
cytoplasmic extract. The protein-RNA complexes were resolved by native gel electrophoresis 
(Fig. 6B.). The 40nt CDE-O probe is shifted into a low mobility complex A, whereas the 
30nt long decay-inactive mutant probe L did not show a shifting complex. Om2 probe shows 
a weaker signal at the corresponding position for complex A, and with the mutant Om3, we 
could observed a complex with a higher mobility than complex A. The Om6 mutant probe 
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FIG. 6. Visualization of the CDE-binding proteins (CDE-BPs) by UV-crosslinking and electrophoretic 
mobility shift assays (EMSA). (A) The CDE-fragment K probe was transcribed in the presence of [α32P]-ATP 
and 4-thio-UTP. 20kcpm of the probe were mixed with 0, 10, 100 or 1000 fold excess of specific competitor 
(unlabelled fragment K) or control competitor (unlabelled TNFα ARE). A mastermix containing 20μg of Raw 
264.7 cytoplasmic extract was added and crosslinked to the probe on ice under a glass plate with 3,6 J/cm2 of 
312nm UV-light. Excess RNA was digested with RNAse A. Protein-RNA complexes were separated by a 7.5 
to 15% gradient SDS-PAGE and visualized by phosphorimaging. The asterisk indicates the undigested probe. 
(B) For EMSA, radiolabelled fragment O, Om2, Om3, Om6 and L were incubated with buffer or with 10μg 
of Raw 264.7 cytoplasmic extract for 30 min on ice. Protein-RNA complexes were separated on a 4% native 
polyacrylamide gel and visualized by phosphorimaging. The asterisks indicate the free probe, whereby the 
upper form probably corresponds to a dimerized form of the probe.
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FIG. 7. Testing of different chromatography 
matrices to purify the CDEBP. Raw 
macrophage extract was incubated with Q 
sepharose, red sepharose, blue sepharose, 
heparin sepharose (hep.) or phenyl sepharose 
(phe.) for 30 min on ice in the presence of 
100mM KCl (lanes 2,4,6,8,10) or 500mM 
KCl (lanes 3,5,7,9,11). The supernatants and 
an untreated control (lane 1) were subjected 
to UV-crosslink assay as described in Fig. 6, 
and separated by 7.5 to 15% gradient SDS-
PAGE and visualized by phosphorimaging. 
The asterisks indicates the free probe, while 
the upper band in lane 3 corresponds to 
undigested probe.
associated, like L, only weakly with proteins and therefore no bandshift could be observed. 
These results suggest that the protein-complexes binding to the CDE-O differ qualitatively 
from the proteins binding to the mutated sequences, which correlates at least partly with 
the loss of decay activities of the mutants as shown in figure 5. These results encouraged us 
that it may be possible to isolate a regulatory protein with specificity for CDE-O, where the 
mutant sequences can serve as important negative controls.
2.2.2 Selection of suitable chromatography matrices to isolate       
         the CDEBP
A prerequisite for chromatographic isolation of the specific 60kD complex 1, depicted in 
Fig. 6A, is to identify a suitable matrix which the protein of interest can bind and be eluted 
from. Specifically we were looking for chromatographic matrices to which the complex is 
able to bind under low salt, but not under high salt conditions (Fig. 7). Cytoplasmic extract 
from LPS stimulated Raw 264.7 macrophages was incubated with the strong anion exchange 
matrix Q sepharose, with the NAD analogue red sepharose, the NADPH analogue blue 
sepharose, heparin sepharose mimicking sugar backbones, or the non-polar matrix phenyl 
sepharose with either a concentration of 100mM KCl (even numbered lanes) or 500mM 
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KCl (odd numbered lanes). The supernatants of these matrices were then analysed by the 
UV-crosslinking system, using the CDE-fragment K as probe, to determine recovery of the 
previously identified complex 1. A crosslinked protein band should be observed at high salt 
conditions, and no crosslinked band under low salt conditions, from the supernatants of 
the binding reactions. The phenyl sepharose matrix works in a contrary manner, because 
hydrophobic interactions are strengthened under high salt conditions. As a positive control 
(lane 1), we used untreated extract, were we could again detect the three complexes as in 
Figure 6 A. Complex 1 was able to adsorb to the Q sepharose matrix and to the heparin 
sepharose matrix under low salt conditions (lanes 2 and 8), but not under high salt conditions 
(lane 3 and 9). In contrast, red sepharose and blue sepharose could adsorb the protein even 
under high salt conditions, indicating that the protein cannot be eluted from the matrix, while 
phenyl sepharose was incapable of binding this protein at all. The properties of Q sepharose 
and heparin sepharose make these two matrices suitable for the purification of complex 1. 
The protein binds to the matrix under low salt conditions, and can be eluted out with high 
salt. For our future work we selected heparin sepharose, followed by an affinity purification 
and anion exchange chromatography.
2.2.3 Overview of the CDE binding protein purification    
  procedure
The approach leading to successful purification of the CDE binding protein is depicted in 
Fig. 8. An overview of the 4-step procedure is described briefly here with detailed results 
following. Raw 264.7 macrophage cells were stimulated with LPS, lysed and precleared 
by centrifugation to obtain the cleared cytoplasmic extract. In step 1 of the purification, the 
extract was applied to a heparin sepharose column, which resembles the sugar backbone 
of RNA, and enables us therefore to select for nucleotide binding proteins. After washing, 
protein was eluted with 1M KCl. In step 2 the proteins eluted from the heparin sepharose 
column were bound to streptavidin sepharose beads precoated with 5’-biotinylated CDE-
fragment K, or with streptavidin sepharose alone as a control. With this CDE-K matrix, we 
introduced an affinity purification step, where specific binding proteins should be selected, 
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whereas most other nucleotide binding proteins will be washed away. After elution of the 
specific binding proteins, we applied step 3 where the eluted protein was purified over a 
Mono-Q anion exchange column. From this matrix, the proteins were eluted over a linear 
FIG. 8. Overview of the CDE-binding protein purification procedure. Raw 264.7 macrophages were 
stimulated with LPS, lysed and precleared by centrifugation. In step 1, the extract was loaded on a HR 10/10 
heparin sepharose column, washed, and eluted with 1M KCl buffer. In step 2, the eluate was bound either to 
streptavidin sepharose (control), or affinity sepharose (streptavidin sepharose preincubated with 5’-biotinylated 
fragment K). The CDE-binding activity was eluted stepwise with 500mM or 1M KCl. The latter fractions 
(control or affinity) were loaded on a Mono-Q column in step 3 and the protein was eluted with a linear gradient 
ranging from 250mM to 1M KCl. All steps were controlled for the presence of the CDE-binding protein by 
UV-crosslinking assays. In step 4, the CDE-binding proteins were visualized on a coomassie gel and the bands 
were cut out and identified by mass spectrometry.
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KCl gradient ranging from 250mM to 1M KCl. In step 4, the fractions containing the CDE 
binding protein were analysed by SDS-PAGE and individual proteins were visualized by 
coomassie blue staining. The protein bands were cut out of the gel and analysed by mass 
spectrometry. The experimental procedures and the single steps of the purification are 
explained in detail below.
2.2.3.1 First step: Heparin sepharose chromatography
For large-scale purification, approximately five litres of growing Raw 264.7 macrophage 
culture were stimulated with 5μg/ml LPS for two hours and harvested by centrifugation. The 
cells were lysed in 30ml of hypotonic lysis buffer and disrupted with a dounce homogenizer 
with 30 strokes of a tight pestle. After preclearing the extract by centrifugation at 15000g for 
10 minutes, we obtained 550mg of cytoplasmic protein and adjusted the KCl concentration 
to 100mM. 60mg of the extract were applied per run to a HR 30/10 heparin sepharose 
column using a FPLC machine at a flow rate of 4ml per minute and fractions were taken 
every minute (Fig. 9A). The flow through fractions 1 to 9 were pooled and the column was 
washed with 10 bed volumes of 100mM KCl buffer that was collected separately as the wash 
fraction, and was eluted first with 250mM KCl buffer (fractions 10 to 13) and in a second 
step with 1M KCl (fractions 16 to 18). The red curve depicts the conductivity, and the blue 
curve the OD
280
 corresponding to the protein amount. Fractions 10 to 13 were pooled as the 
250mM KCl fraction, and fractions 16 to 18 as the 1M KCl fraction and the proteins were 
analysed by SDS-PAGE followed by silver staining (Fig. 9B), and UV-crosslinking using 
a radioactive CDE probe (Fig. 9C). Most of the protein was present in the flow through 
fraction (Fig. 9B, lane 2), and in the 250mM KCl step fraction (lane 4), whereas the wash 
fraction (lane 3) and the 1M KCl fraction (lane 5) contained no detectable protein. The gel 
was dried and exposed to a phosphorimager screen (Fig. 9C). Complex 1 was barely visible 
in the input fraction (lane 1), and not at all in the flow through and wash fractions (lanes 2 
to 4). However, complex 1 was highly enriched in the 1M KCl fraction (lane 5), although 
no protein was detectable by silver staining. This can be explained by the higher sensitivity 
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FIG. 9. Step 1: Purification of the CDE-BP over a heparin sepharose column. (A) Raw 264.7 cytoplasmic 
extracts were applied to a HR10/10 heparin sepharose column using a FPLC-machine. The red curve shows the 
conductivity and the blue curve the OD
280
. The flowthrough (Fractions 1 to 9), a wash fraction, the 250mM KCl 
fraction (Fractions 10 to 13) and the 1M KCl fraction (Fractions 16 to18) were collected. (B and C) Raw 264.7 
extract (lane 1), flow through (lane 2), a wash fraction (lane 3), a 250mM KCl fraction (lane 4) and a 1M KCl 
fraction (lane 5) were subjected to UV-crosslinking with the radiolabelled CDE-probe K as described in Fig. 6, 
and separated by 7.5% to 15% gradient SDS-PAGE. (B) Protein bands were visualized by silver staining, and 
(C) protein-RNA complexes by phosphorimaging. The asterisks indicates the free probe, and the undigested 
probe in lane 2 (upper band).
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of the UV crosslinking assay compared to silver staining, and is also an indication that the 
protein we are trying to purify is still functional, a necessary requirement for the next step 
of purification.
2.2.3.2 Second step: CDE affinity purification 
The 1M KCl fraction from Fig. 9 was dialysed against buffer A pH 8.0 containing 100mM 
KCl. One half of the eluate was bound to streptavidin sepharose beads precoated with 5’ 
biotinylated CDE-K, and the other half was incubated with streptavidin sepharose alone as a 
control, and rotated overnight at 4°C. Both samples were washed identically and in parallel 
with a buffer containing 500mM KCl and eluted with 1M KCl. Each of these fractions was 
tested by UV-crosslinking with a radioactively labelled CDE probe followed by SDS-PAGE. 
In the silver stained gel (Fig. 10A), most protein remained in the supernatant (lanes 2 and 5), 
whereas no protein was eluted with 500mM and 1M KCl from the streptavidin control (lanes 
3 and 4). From the affinity matrix some protein could be eluted with 500mM KCl (lane 6), 
but no detectable amounts were visible in the 1M KCl fraction (lane7). After phosphorimager 
exposure (Fig 10. B), only a slight band can be observed at the position of complex 1 in the 
input and control supernatant (lanes 1 and 2), but the activity was strongly enriched in the 
1M KCl elution fraction (lane 7) of the affinity matrix. The activity was depleted completely 
in the affinity matrix flow through (lane 5), and was barely visible in the 500mM KCl wash 
fraction (lane 6). Complex 1 could not be pulled down with the control beads (lanes 3 and 
4), indicating that the CDE binding protein does not interact with the matrix alone. The 1M 
KCl fraction from the affinity chromatography was used for further testing to confirm that a 
CDE-specific protein was obtained. Before proceeding in the purification procedure it was 
necessary to confirm whether this crosslink-activity is specifically binding to the CDE-O, but 
not fragment L, as observed in Fig. 6B. In an electrophoretic mobility shift assay (EMSA), 
we incubated 32P labelled CDE-O (promoting decay in vivo) and fragment L (inactive) with 
the 1M KCl affinity elution fraction and separated the complexes on a 4% non-denaturing 
polyacrylamide gel (Fig. 10C). With the CDE-O, a complex could be detected that is absent 
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FIG. 10. Step 2: Purification of the CDE-BP by 
affinity chromatography. (A and B) The 1M KCl 
fraction of heparin sepharose (lane 1) was incubated 
with streptavidin sepharose (control, lanes 2 to 4) or 
5’-biotinylated CDE-fragment K coupled to streptavidin 
sepharose (lanes 5 to 7) rotating overnight at 4°C. The 
supernatants (lanes 2, 5) were removed and the matrices 
were washed with a 500mM KCl buffer (lanes 3, 6) and 
eluted with a 1M KCl buffer (lanes 4, 7). The affinity 
fractions were UV-crosslinked with the radiolabelled 
CDE-K probe as described in Fig. 6 and separated by 
7.5% to 15% gradient SDS-PAGE. Protein bands were 
visualized by silver staining as shown in (A), and protein-
RNA complexes revealed by phosphorimaging (B). The 
asterisks indicates the free probe. (C) For EMSA, the 
affinity fraction or buffer were diluted and mixed with 
radiolabelled CDE-probe O or L and incubated for 30min on ice. Protein-RNA complexes were separated on a 
4% native polyacrylamide gel. The complexes were visualized by phosphorimaging. The asterisks indicate the 
free probe, where the upper band indicates a putative dimerized probe.
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when incubated with the water control, or when the affinity purified protein is incubated 
with fragment L. This result encouraged us to continue with the third step of purification and 
confirms the correlation of the in vivo decay activities of the CDE-O and mutant L to the 
activity visualized by the UV-crosslinking experiments. 
2.2.3.3 Third step: Anion exchange chromatography
The elution fraction from the affinity purification (Fig. 10A and B, lane 7) or streptavidin 
sepharose (Fig. 10A and B, lane 4), was diluted 1:10 with buffer A to reduce the KCl 
concentration to 100mM, and applied to a prepacked Mono-Q column, using an FPLC 
machine, which was subsequently washed with a 250mM KCl containing buffer. The bound 
proteins were eluted with a linear KCl gradient ranging from 250mM to 1M KCl, and 0.5ml 
fractions were collected. In the Mono-Q fractions derived from the streptavidin control 
eluate no crosslink activities were visible (data not shown). The results obtained with Mono-
Q chromatography, after affinity-K purification, are shown in Fig. 11A. Fractions 2 to 5 
contained the flow through and 6 to 15 the 250mM KCl wash fractions. In fractions 16 to 23, 
collected from the gradient elution, several protein “peaks” were visible (indicated by black 
arrows). The Mono-Q fractions were assayed by UV-crosslinking using the radioactively 
labelled CDE-K probe, to identify the fractions containing the CDE binding protein, and to 
estimate the proteins size (Fig. 11B). We could detect four crosslinking activities in fractions 
17 to 21, with molecular weights of 45, 50, 70 and 100kD. The bands at 45 and 50kD would 
correspond to complex 1, although the size of this complex is smaller than observed in Fig. 
6A. Possible reasons could be proteolytic degradation of the protein, a discrepancy between 
the different sets of protein markers used, or the influence of the elevated amounts of KCl 
in these fractions. Furthermore, we co-eluted the band at 70kD, probably corresponding 
to complex 2, , which binds non-specifically to the CDE as it could not be competed by 
unlabelled CDE-K and TNFα-ARE
53
 in Fig. 6A. Nevertheless, we decided to identify the 
protein by mass spectrometry.
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FIG. 11. Step 3: Purification of the CDE-BP by anion exchange chromatography. (A) The affinity purified 
fractions (Fig. 10) were applied to a HR 5/5 Mono-Q column using a FPLC-machine. The flow through 
(fractions 2 to 5) was collected, and the column was washed subsequently with 100mM and 250mM KCl 
(Fractions 6-14). Proteins were eluted from the column with a linear KCl gradient ranging from 250mM to 
1M KCl and fractions 15 to 23 were collected. (B) Fractions 5 and 15 to 23 were subjected to UV-crosslinking 
using a radiolabelled CDE-K probe as described in Fig. 6, separated by 7.5% to 15% gradient SDS-PAGE. 
Protein-RNA complexes were visualized by phosphorimaging.
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2.2.3.4 Fourth step: Mass spectrometry
The proteins from the Mono-Q fractions 17 to 21, derived from the 1M KCl eluate of 
the streptavidin control or the CDE-affinity purification, were precipitated, alkylated and 
resolved by a 7.5 to 15% gradient SDS-PAGE and visualized by coomassie blue staining 
(Fig. 12A). While the fractions from the Mono-Q column loaded with the streptavidin 
control fraction were devoid of protein, ten bands were visible in the affinity-derived Mono-
Q fractions. The two bands visible in fractions 17 to 19 between the 40 and 50kD marker 
could correspond to the complex 1, where the protein amounts correlate with the crosslinking 
intensity of Fig. 11B. Another band in fraction 20 ran at the level of the 60kD marker, which 
would correspond to the non-specific complex 2 that was also visible in the UV-crosslinking 
assay (Fig 11B). 
In a second experiment following the same purification scheme (Fig. 12B), we pooled the 
fractions 17 to 19 in lane A, and 20 to 21 in lane B, and after precipitation and alkylation, 
the purified proteins were visualized by coomassie staining. All visible bands were cut out 
and sequenced by MALDI-TOF and tandem mass spectrometry (MSMS) by Dr. Evers and 
Mr. Roeder at F. Hoffmann La-Roche, Ltd. Band 1 was identified as the protease cathepsin 
K, band 11 as the protein chaperone GRP 78, and band 12 as mouse keratin. The other seven 
bands corresponded to the RNA-binding protein nucleolin and its degradation products. 
Nucleolin consists of an alternating basic acidic domain at the N-terminus, a central domain 
with four RNA recognition motives (RRMs), and a C-terminus with an RGG domain 
(Bourbon et al. 1988). The structure of the entire protein and the fragments identified by mass 
spectrometry are schematically depicted in Fig. 12C. The peptides identified in the bands 2 
to 5 are all located in the region of the RRM1 and 2, whereas bands 6 to 9 and 11 contained 
peptides from all four RRMs. Peptides from the N-terminus or the RGG domain could not 
be identified. Band 10 could be identified by MSMS only. In this purification experiment we 
did not obtain full-length nucleolin, which would run at a molecular weight of 110,000. 
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FIG. 12. Step 4: Nucleolin was identified as a CDE-BP by mass spectrometry. (A) Protein from the Mono-
Q fractions were precipitated, alkylated and loaded on a 7.5% to 15% SDS-polyacrylamide gradient gel. 
Protein was visualized by coomassie staining. (B) From a repeat purification, fractions 17 to19 were collected 
in pool A, and fractions 20 to 21 in pool B. The pools A and B were precipitated, alkylated and analysed by 
7.5% to 15% gradient SDS-PAGE. Protein was visualized by coomassie staining and the bands 1 to 12 were 
cut out and identified by MALDI-TOF and MSMS. The table shows all 12 bands identified. (C) Nucleolin is 
schematically depicted. It contains three acidic domains in the N-terminal domain, 4 RRMs in the central part, 
and a C-terminal RGG domain. The peptides identified from bands 2 to 5 were distributed over the RRMs 1 
and 2 and bands 6 to 9 over the RRMs 1 to 4. The peptides are indicated by black bars.
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2.2.4 Nucleolin can be precipitated with RNA coated beads
Nucleolin was discovered as a highly expressed protein in the nucleus (Orrick et al. 1973; 
Prestayko et al. 1974), and is divided into three functionally distinct parts. The N-terminus 
contains three acidic domains, which are interspersed by basic stretches and is reported to 
be a protein interaction domain. The central part contains four RRMs, which are only 10% 
identical to each other. The RRMs make specific contact with different target sequences 
like the Jun-kinase responsive element (JRE) (Chen et al. 2000), the bcl-2 ARE (Sengupta 
et al. 2004) or the well characterized nucleolin recognition element (NRE) which is found 
in the rRNA precursor and is involved in ribosome biogenesis (Serin et al. 1996). The NRE 
consensus sequence was defined by the SELEX method as a short stem loop (Ghisolfi-Nieto 
et al. 1996), and this sNRE (for SELEX-NRE) is bound by nucleolin with high affinity. The 
C-terminal domain contains RGG-repeats that are relevant for protein-protein interaction 
with ribosomal proteins and hnRNP A1 (Cartegni et al. 1996; Bouvet et al. 1998) and 
can also bind non-specifically to RNA (Ghisolfi et al. 1992), which makes it necessary to 
rigorously confirm the binding specificity of nucleolin to a target sequence. Initially, we 
wanted to know whether nucleolin is the only protein binding to the CDE-fragment O. We 
incubated Raw 264.7 macrophage extract with beads precoated with either a 5’ biotinylated 
sNRE oligonucleotide or the biotinylated fragment CDE-K and uncoated beads were 
used as a control. After the binding reaction, the supernatant was removed and the beads 
thoroughly washed. Proteins associated with the oligomers were eluted with 1M KCl, and 
the protein fractions were analysed by EMSA using radiolabelled CDE-O as the probe (Fig. 
13A). Depletion with the CDE and NRE matrices resulted in greatly diminished or absent 
protein-RNA complexes A and B in the depleted supernatants (NRE and CDE) compared to 
the input and the control (Ctr) supernatant. The band shift activity could be recovered in the 
elution fractions from the CDE and NRE coated beads, see Fig. 13A and B, but not in the 
elution fraction of the control (Ctr) lane. By western blot with a nucleolin-specific antibody 
(Fig. 13B), we could show that nucleolin was indeed removed from the cytoplasmic lysate. 
It was only detected in the input, the control supernatant and in the pellets of the NRE and 
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FIG. 13. Nucleolin can be precipitated with RNA coated beads from Raw 264.7 lysates. (A) Raw 
264.7 macrophage extracts were incubated with 5’-biotinylated sNRE coupled to streptavidin sepharose, 
5’-biotinylated CDE-O coupled to streptavidin sepharose or streptavidin sepharose alone overnight at 4°C. 
The supernatants were transferred to a new tube and the beads were washed several times. The bound protein 
was eluted with a 1M KCl buffer (Eluate). Raw cytoplasmic extract (Input), a buffer control (Probe) and 
the fractions were incubated with a radiolabelled CDE-O-probe for 30 min on ice. Protein-RNA complexes 
were separated on a 4% native polyacrylamide gel and visualized by phosphorimaging. The asterisks indicate 
the free probe. (B) The nucleolin levels in the different fractions were determined by western blot using a 
nucleolin-specific antibody. (C) The pull-down was repeated as in (A), except that a control, corresponding to 
40nt of the IL-3 3’UTR, was included (IL3). The input, the different supernatants and eluates were analysed by 
western blot using a nucleolin-specific antibody.
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CDE affinity matrices. Nucleolin eluted from the sNRE seems to be under-represented. One 
explanation could be that the elution from the sNRE beads was not quantitative due to its high 
affinity for nucleolin. It was also observed, that full-length nucleolin was eluted in this pull 
down assay, whereas in the purification strategy used to identify nucleolin, only fragments 
could be obtained. It is possible that extensive handling during the purification process, results 
in some degradation of nucleolin, whereas the comparatively simple depletion experiments 
only take a short time, resulting in an intact protein. In this experiment no other protein than 
nucleolin appears to be associated with the CDE and we concluded that nucleolin is a likely 
candidate to be associated with the CDE. Subsequently a similar approach using a 40nt long 
5’biotinylated sequence from the IL-3 3’UTR (IL-3) as a non-specific precipitation control 
in western blot was performed (Fig. 13C). As shown before, the NRE and the CDE coated 
beads cleared nucleolin from the supernatant compared to the streptavidin control (Ctr), but, 
unfortunately, so did the IL-3 3’UTR-sequence (IL-3). Nucleolin could again be recovered 
from the beads (IL-3, NRE and CDE) but not from the control (Ctr). This raised again the 
question as to whether the nucleolin-CDE interaction is really specific, and not merely 
mediated by the non-specific binding activity of the RGG domain.
2.3 Part III: Functional assays 
2.3.1 Nucleolin binds to CDE-O, but not the mutants
As the pull down experiment demonstrated, it is critical to prove that the nucleolin-CDE 
interaction is specific. To resolve this problem, we decided to test the CDE-O and the derived 
O-mutant sequences in bandshift experiments, as we had earlier shown in this work that 
the affinity-purified protein could discriminate between the CDE-O and fragment L RNA 
(Fig. 10C). Here we tried to repeat this result with cytoplasmic extract and the wild type 
and mutant probes of O, and to prove whether any activities observed are identical with 
nucleolin, we would try to super shift the complex with a anti-nucleolin antibody. If the 
CDE-O probe binds to nucleolin and not to its mutants, this would indicate specificity of 
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FIG. 14. Nucleolin binds specifically to fragment O. (A) 10μg THP-1 human macrophage extract was 
preincubated with anti-nucleolin (NCL) or anti-glutathione-S-transferase (GST) antibody for 30 min on ice, 
and then mixed with 10kcpm of radiolabelled CDE-probe O or L, and incubated for a further 30min on ice. 
Protein-RNA complexes were separated on a 4% native polyacrylamide gel. The complexes were visualized by 
phosphorimaging. Asterisks indicate the free probe, and the cross indicates a non-specific band. (B) EMSA was 
repeated as in (A) using CDE-probe O and the mutants Om2, Om3, Om5, Om6 and L, and a nucleolin-specific 
antibody for supershift. Asterisks indicate the free probe, and the cross indicates a non-specific band.
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nucleolin for the CDE-O. Therefore 10μg of THP-1 extract was incubated with 10kcpm of 
radiolabelled probes O and L (Fig. 14A). Several non-specific protein-RNA complexes were 
observed that bound to both L and O. However, there was one band that was only observed 
with the CDE-O probe. To confirm that this is nucleolin, we used a mouse monoclonal anti-
nucleolin antibody (MS3 Santacruz) and a control anti-GST antibody to perform a super 
shift. The band unique to O could be super shifted with the anti-nucleolin antibody, but not 
with the anti-GST control antibody, proving that the band unique to O is indeed nucleolin. 
To correlate the in vitro binding of nucleolin with the in vivo activity of the different 
mutants, we repeated the band shift experiments using 10kcpm of radiolabelled probes of 
all the mutant-O sequences and 10μg THP-1 cytoplasmic extract (Fig. 14B). We observed 
that nucleolin binds strongly to the fragment O, but only weakly or not at all to any of the 
mutant sequences. Binding of nucleolin to fragment O was confirmed by super shift assays 
with a specific anti-nucleolin antibody. Therefore we conclude that nucleolin binding in vitro 
correlates with rapid CDE mediated mRNA decay in vivo. 
2.3.2 Preparation of recombinant nucleolin
To investigate the nucleolin-CDE binding further using well-defined reagents, we decided to 
produce recombinant nucleolin using the baculo-virus expression system. 
An overview of the recombinant GST-nucleolin production from vector to protein is depicted 
in Fig. 15A. Nucleolin was amplified by PCR from Raw macrophage cDNA with the primers 
Nucleolin-baculo and Nucleolin-AntiS, and was inserted together with a tobacco etch virus 
(TeV) protease recognition site into the donor plasmid pFastbac GST (Brondani et al. 2005). 
This vector was transformed into DH10Bac E.coli cells, which contained a bacmid encoding 
for the baculovirus genome that was modified by insertion of the lacZ gen and the attTn7 
recombination site. The GST-TeV-Nucleolin DNA recombined with the attTn7 site via its 
Tn7 recombination site disrupting the lacZ gene. Positive GST-TeV-nucleolin bacmid clones 
were isolated by selection with kanamycin, gentamycin and tetracycline followed by blue-
white selection. The bacmid was then extracted from the bacteria and transfected into High5 
Results
62
Results
63
FIG. 15. Expression of recombinant nucleolin with the baculovirus expression system. (A) The GST-
fastbac donor vector (Brondani et al. 2005) containing the full-length nucleolin sequence was transformed into 
DH10Bac E.coli cells containing the baculovirus genome. The GST-nucleolin fusion sequence was integrated 
into the baculovirus genome via its Tn7 recombination sites, and after selection the recombinant baculo-bacmid 
was extracted from the E.coli cells and transfected into High5 insect cells for baculovirus production. The 
virus-containing supernatant was harvested and High5 cells were infected repeatedly to obtain high expression 
of the recombinant protein. (B) Uninfected cells (lane 1,2), or cells infected with two different baculovirus 
clones (lane 3 to 6) were lysed and centrifuged to obtain soluble fraction (lanes 1,3,5) and an insoluble pellet 
(lane 2,4,6). The expression of recombinant GST-nucleolin was shown by western blot.
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insect cells, which produced high amounts of the recombinant virus. The cells were lysed 
after the second round of infection, after sufficient protein is produced. To confirm GST-TeV 
nucleolin production (Fig 15. B.), High5 cells were infected with two independent virus 
productions, namely baculo-clone1 (lane 3 and 4) and baculo-clone2 (lane 5 and 6) or a GST 
control virus (lane 1 and 2). The cells were lysed and the insoluble fraction was spun down in 
a centrifuge. An aliquot of the soluble (odd numbered lanes) and the insoluble fraction (even 
numbered lanes) were analysed by western blot with an antibody specific for nucleolin. Both 
clones, but not the control contained the recombinant protein. Unfortunately, most of the 
desired fusion protein was insoluble (lanes 4 and 6), and could not be brought into solution. 
We purified the recombinant nucleolin from the soluble fraction with GST sepharose.
2.3.3 Recombinant nucleolin binds strongly to fragment O, but   
         not to Om2 or L 
Apart from its known target sequences, nucleolin is also able to bind RNA non-specifically 
by virtue of its RGG domain (Ghisolfi et al. 1992). Therefore we wanted to determine if 
recombinant nucleolin can discriminate between the fragment O and mutated CDE sequences. 
We expressed the construct shown in Fig. 15A. as well as a GST control construct in High5 
insect cells using the approach described above. The GST or GST-nucleolin expressing 
High5 cells were lysed, and GST or GST-nucleolin was bound to GSH-sepharose. After 
three rounds of washing and one round of equilibration with the TeV buffer, nucleolin could 
be eluted by TeV protease cleavage, resulting in untagged, soluble nucleolin. Fractions from 
every working step were analysed by western blot using an anti-nucleolin specific antibody 
(Fig. 16A. data for GST control not shown). GST nucleolin was present in the input and in 
the supernatant (lanes 1 and 2), but not in the wash and equilibration fractions (lanes 3 to 
6). A nucleolin band could be detected after elution by TeV cleavage for 1h at 4°C, which 
had a higher mobility than the GST-nucleolin fusion protein and corresponded to untagged 
nucleolin (lane 7). To assess the purity of the recombinant protein, the eluted nucleolin 
(lane N) and the GST control (lane C) were viewed on a coomassie gel (Fig. 16B). The 
control lane is bare, but in the eluted fraction a band corresponding to the size of nucleolin 
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was observed together with other bands, which may be either copurified proteins from 
insect cells or degradation products of nucleolin. We next wanted to know if the purified 
full-length nucleolin is biologically active. This was tested in an EMSA using 100ng of 
the recombinant nucleolin. For a positive control we used 5kcpm of radiolabelled selex 
nucleolin recognition element (sNRE, a well established nucleolin target), and a mutant 
NRE sequence (mNRE) originally referred to as NS26A18C as a specificity control (Fig. 
FIG. 16. Purification and testing of recombinant nucleolin. (A) High5 extracts containing recombinant GST-
Nucleolin (lane 1) were bound to glutathione sepharose matrix. The supernatant (lane 2) was removed and the 
matrix was washed three times (lanes 3 to 5). After equilibration with TeV-protease buffer (lane 6), nucleolin 
was released by TeV-protease (lane 7). The fractions were separated by SDS-PAGE, and nucleolin was detected 
by western blot using a specific anti-nucleolin antibody. (B) GST-control (lane C) and nucleolin eluates (lane 
N) were analysed by SDS-PAGE and coomassie blue staining. (C) Recombinant nucleolin was tested by EMSA 
as described in Fig. 4, using radioactively labelled SELEX-selected nucleolin recognition element (sNRE) and 
a mutant NRE (mNRE) as probes. (D) The same experiment was performed using radiolabelled probes for O, 
Om2 and L. Asterisks indicate the free probe.
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16C) (Johansson et al. 2004). The sNRE was defined in a selex experiment as a nucleolin 
target sequence binding with high affinity to nucleolin (Ghisolfi-Nieto et al. 1996). Similar 
sequences were previously defined on the pre-ribosomal RNA, a physiological target of 
nucleolin (Serin et al. 1996). The affinity of sNRE and NRE-mutants were later tested by 
biacore assays to assess the nucleotides relevant for nucleolin-NRE binding. There the K
D
 
value of sNRE was determined at 2 to 5nM and for the mNRE at more than 50μM, making 
them ideal controls for this experiment (Johansson et al. 2004). As expected, a shift could be 
observed with the sNRE probe (lane 2) indicating proper folding and biological activity of 
the recombinant nucleolin, but not with the mNRE (lane 4). The probes alone are shown in 
lane 1 and lane 3 respectively. Finally, we wanted to demonstrate that recombinant nucleolin 
is able to distinguish between radiolabelled fragment O, L and Om2 probes (Fig. 16D). In 
a band shift assay, we observed a shift of the probe O with 100ng of recombinant nucleolin 
(lane 3), but not with a GST-control fraction (lane 2). Probes Om2 and L showed greatly 
reduced nucleolin binding (lane 6 and 9). The control fractions were not able to induce a 
band shift with any probe (lanes 2, 5, and 8). Lanes 1, 4 and 7 show the integrity of the 
radioactively labelled probes. These results support our data obtained with THP-1 extracts 
and the correlation between nucleolin binding and in vivo CDE activity.
2.3.4 Nucleolin interacts with TNFα mRNA in vivo
The results so far demonstrate that nucleolin can interact with the functional CDE in vitro, 
and shows no or greatly reduced binding to inactive CDE-mutants. To test whether nucleolin 
and the CDE indeed interact in vivo, we performed RNA-immunoprecipitation assays with 
endogenous nucleolin and TNFα mRNA. It would strengthen our binding data, if endogenous 
TNFα mRNA could be pull-down together with nucleolin. For this we prepared cytoplasmic 
extract from THP-1 human macrophages, which was precleared by centrifugation. 2mg of 
this extract were added to protein G sepharose beads precoated with the specific antibodies 
against the myc epitope (control), the ELAV protein HuR and nucleolin (Lopez de Silanes 
et al. 2004a; Takagi et al. 2005) in the presence of RNAse inhibitors. HuR was previously 
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shown to bind the TNFα-ARE, and was therefore used as a positive control. After the 
extract was incubated with the coated beads for 2h at 25°C, the supernatant was removed, 
and the beads were washed ten times with buffer NT2. Finally the RNA and protein was 
eluted from the beads with buffer NT2 containing 0.1 % SDS at 65°C. Western blot was 
performed to test whether HuR and nucleolin can be pulled down under these conditions 
(Fig. 17A). In the input and myc supernatant fraction, nucleolin, HuR and GAPDH were all 
detected by their corresponding antibodies. HuR was greatly reduced in the supernatant of 
the HuR coated beads, but could be recovered from the HuR pellet, indicating it is a very 
effective precipitating antibody. Nucleolin was not so effectively pulled down by its specific 
antibody. Substantial amounts of nucleolin are still visible in the supernatant, and only 20 
to 50% of nucleolin could be pulled down with the nucleolin specific antibody. GAPDH, 
our negative control protein, was not precipitated by any of the antibodies used, and the 
myc control antibody was not able to pull down nucleolin, HuR or GAPDH, indicating 
that the washing of the beads was sufficient. Although the pull-down of nucleolin was 
incomplete, it was nevertheless sufficient to proceed with RNA-IP and isolation of RNA. 
For the RNA-IP experiment, we prepared extracts from unstimulated and LPS stimulated 
THP-1 macrophages (4h). LPS induces the levels of TNFα mRNA and that of our control 
cytokines IL-6 and IL-10, which are barely visible under unstimulated conditions. Another 
effect of LPS on macrophages is that HuR, the positive control, translocates from the nucleus 
to the cytoplasm, so that more HuR bound TNFα message can be detected. The RNA-IP was 
performed on these lysates. After the RNA-IP was performed as described above, the eluted 
RNA was purified using the RNeasy mini kit (Qiagen). The RNA from the input, and from 
the precipitated RNP complexes were reverse transcribed to cDNA. From this cDNA we 
amplified the various messages by 35 rounds of PCR (Fig. 17B). GAPDH specific primers 
were used as a contamination control. This house keeping gene is highly expressed, and 
would indicate immediately if the beads were not sufficiently washed. Therefore, it should 
only be detectable in the input (I), but not in the pellet (P), as was the case in this experiment. 
A further control was a parallel pull-down using an anti-myc antibody. This antibody is not 
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FIG. 17. The TNFα mRNA interacts with nucleolin in vivo. (A) THP-1 cell extracts were incubated with 
anti-myc, anti-nucleolin or anti-HuR coated protein G-sepharose beads for two hours at room temperature. 
Supernatants were removed and beads were washed ten times. Protein was eluted from the beads with 0.1% 
SDS at 65°C. The input, supernatants and protein of the pellets were analysed by western blot. The cross marks 
an unspecific band. (B) THP-1 cells were treated as above, and RNA was eluted from beads with 0.1% SDS 
and 10μg proteinase K at 50°C. RNA from inputs (I) and pellets (P) was purified, and RT-PCR was performed 
using specific primers for TNFα, GADPH, IL-6 and IL-10.
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expected to pull down any message due to the absence of a binding target protein in the THP-
1 cells, and this proved to be the case from the lack of any message from the pellet (P). IL-6 
and IL-10 are cytokines that contain an ARE in their 3’UTR. Both messages are expressed in 
LPS stimulated cells, but were not pulled down by the nucleolin or HuR specific antibodies. 
These two messages acted as a specificity control for HuR, to exclude artificial interactions 
that are established after the cells were disrupted. HuR and nucleolin both displayed a 
significant association to the TNFα message, which was increased after LPS stimulation. 
This indicates that nucleolin indeed is associated with the TNFα mRNA in vivo and supports 
our hypothesis that nucleolin may be a regulator of TNFα-mRNA turnover. This encouraged 
us to investigate further the involvement of nucleolin in CDE-mediated decay.
2.3.5 Knockdown of nucleolin with siRNA causes an increase of  
         GFP protein in a GFP-CDE reporter cell line
Having confirmed the interaction between nucleolin and the CDE, a RNA-destabilizing 
element, we wished to observe the effect of nucleolin depletion on a CDE-bearing reporter 
gene. Nucleolin levels were down-regulated by siRNA in HT1080 cells stably transfected 
with a GFP-CDE reporter (Fig. 18A), and the behaviour of this reporter was monitored 
by analysing the changes in GFP-levels by fluorescence activated cell sorting (FACS) 
(Benjamin et al. 2004). Double transfection of two different nucleolin specific siRNAs, 
NCL-2 (lane 4) and NCL-3 (lane 5), resulted in a substantial reduction in nucleolin protein 
levels, whereas a reduction of nucleolin levels could not be observed with a HuR (lane 3), 
a BRF1 (lane 2) specific siRNA or an untransfected control (lane 1). The protein levels of 
GAPDH were not influenced by any of the siRNAs. Interestingly, the levels of HuR was not 
only reduced by the HuR specific siRNA (lane 3), but also by the nucleolin specific siRNAs 
(lanes 4 and 5) for unknown reasons, albeit not as strongly. A decrease in translation induced 
by nucleolin down regulation could be responsible for this effect, although this was not 
observed with the GAPDH protein. One could even speculate that nucleolin my influence 
HuR expression. By FACS analysis we observed that transfection of both siRNAs directed 
against nucleolin (green) were able to cause an increase in GFP expression levels compared 
Results
70
Results
71
to the untransfected control (black), the si-BRF1 (orange) or si-HuR (red) treated cells (Fig 
18.B and C). Furthermore, both nucleolin specific RNAs had a similar effect in increasing 
GFP expression levels thus reducing the possibility of an off-target effect caused by siRNA 
transfection. Although this result is consistent with our hypothesis, it remains to be prove, 
if nucleolin influences GFP-reporter mRNA stability or if the observed increase of GFP-
expression is caused by other means.
FIG. 18. Knockdown of nucleolin causes an increase in GFP protein levels in GFP-CDE reporter cells. 
(A) HT1080 GFP-CDE reporter cells were transfected twice with siRNA against BRF1 (lane 2), HuR (lane 3) 
and two different siRNAs against Nucleolin (lane 4 and 5) or not at all (lane 1). Total cell lysates were harvested 
72h after transfection, and separated by SDS-PAGE. Knockdown of the respective genes was confirmed by 
western blot. (B and C) GFP levels of the control and siRNA transfected cells were analysed by FACS.
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2.3.6 Effect of nucleolin downregulation on the GFP-CDE  
         reporter mRNA stability
The shift in GFP protein levels observed in Fig. 18B and C may be due to reasons other than 
a change in the decay rate of this reporter, such as increased transcription or translation rates. 
To clarify this question, we performed actinomycin D mRNA decay chase experiments. We 
transfected 15cm dishes of HT1080 GFP-CDE cells with the previously described siRNAs. 
After 48 hours, the cells were split equally into three 10cm dishes, and after 72 hours the 
cells were treated with actinomycin D to arrest transcription. Cells were harvested over a 
time course for total RNA extraction. The RNA was analysed by northern blotting with a 
specific probe against the TNFα 3’UTR. This experiment was repeated several times, and 
a typical experiment is shown in Fig. 19A. We observed that the reporter from cells treated 
with both the nucleolin specific siRNAs decayed slower than in the untreated cells or cells 
transfected with the control siRNA oligomer. The amount of endogenous GAPDH mRNA 
was not changed under any of the conditions. The amount of GFP reporter mRNA left after 
one or two hours with actinomycin D was normalized against the GAPDH control. The 
mean of all experiments indicated in table 1 was calculated and plotted against time (Fig. 
19B). The half-lives and standard deviations were calculated (table 1), and the statistical 
significance was calculated by the student (t) test. Although the changes in decay rate are 
not dramatic, down-regulation of nucleolin (green) increases the CDE-reporter half-life by 
more than 30 percent from 96 to 134 minutes, compared to the down-regulation of BRF1 
(orange), HuR (red) or untransfected cells (black). This 30% increase in half-life resulted 
in a 3 to 4 fold increase in protein levels, which would be sufficient in the case of TNFα to 
induce autoimmune disease or rheumatoid arthritis over time. 
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FIG. 19. Knockdown of nucleolin influences GFP-CDE reporter RNA half-life. (A) The siRNA transfected 
HT1080 GFP-CDE reporter cells (Fig. 18) were treated with act. D for 0, 1 or 2 hours. Total RNA was 
extracted, and analysed by northern blot. Reporter RNA was detected using a radiolabelled probe specific for 
the TNFα 3’UTR. To control loading, the membranes were rehybridized with a probe against GAPDH. (B) 
Reporter levels were quantified with Quantity One and normalized against the loading control. Percentage of 
decay was plotted against time. The student(t) test was applied to determine the statistical significance.
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3. Discussion
3.1 The CDE is a rapid decay element
In this work we have investigated the function of the constitutive decay element (CDE) 
that is located downstream of the ARE in the 3’ UTR of the TNFα message. The CDE was 
originally discovered in slowC cells that are deficient in ARE dependent decay due to a 
frame shift mutation in both alleles of the AU-binding protein BRF1. A reporter containing 
the entire 3’ UTR of TNFα was degraded rapidly, with a half-life of about 45 minutes, 
whereas a reporter containing just the defined ARE sequence was stable for over more 
than 6 hours in these cells. By deletion mutagenesis, the CDE could be mapped to an 80-
nucleotide long sequence (KΔAU) located 20 nucleotides downstream of the TNFα-ARE
53
. 
It contains a highly conserved region with a putative stem loop region, and was degraded 
with a half-life of 1.7 hours, approximately 2.5 times slower than the complete 3’UTR in 
slowC cells (Stoecklin et al. 2003). In the present work, we were able to further reduce the 
size of the active CDE to a minimum of 40 nucleotides (fragment O) by deletion mapping 
(Fig. 4). Surprisingly, a reporter mRNA containing this minimal CDE was degraded even 
more rapidly than the KΔAU-fragment, and followed similar kinetics as the entire region 
downstream of the ARE with a half-life of 45 minutes. It is therefore conceivable, that the 
longer KΔAU fragment contains a sequence that negatively influences the decay activity, 
either via an altered mRNA secondary structure, or by means of active stabilization via 
stabilizing proteins. Another possibility could be the deletion of two bases at the 3’ terminus, 
which were included in CDE-O but not in the KΔAU fragment (Fig. 4A). When we stably 
introduced the reporter constructs bearing the decay-promoting CDE-fragment O and the 
inactive fragment L into NIH 3T3 cells, we were able to confirm the rapid decay kinetics 
from transient transfection experiments, and the increased reporter expression in stable cell 
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lines allowed us to observe rapid deadenylation of fragment O. Deadenylated products could 
already be detected at time point zero, hinting at the power of the CDE in mediating rapid 
decay (Fig 4D).
By M-fold RNA structure prediction, a putative stem-loop was discovered in the CDE. 
Mutations in the loop region and the stem rendered the slow-decaying CDE fragment K 
non-functional, which however could not be reversed by restoring the base pairing by 
complementary mutations (Stoecklin et al. 2003). It is also striking that the fragment O 
is very U-rich, which is a common feature of destabilizing motifs (Chen and Shyu 1995; 
Peng et al. 1996), and we presumed that the CDE-O might act as a class-III ARE. We also 
postulated, that the 5’ region that is present in O but absent in L was responsible for the 
inactivity of fragment L in promoting decay. Therefore we introduced mutations in three of 
the seven Us of the stem and loop implicated by Stoecklin et al. and changed the first four 
nucleotides from CUUC to AGGA in the CDE-O (Om2) (Fig 5A). In mutant Om3 only the 
first four residues were changed in order to assess the relevance of the first six nucleotides 
that were deleted in L compared to O. Two additional mutants were create, which retained 
the U-rich region of the CDE, Om6 where the 3’ terminal six nucleotides were deleted, and 
Om5 which contains an internal deletion of six nucleotides. All mutants were subsequently 
tested for decay promoting activity. It was clear that the introduction of any mutation into 
fragment O leads to a loss of function of this cis-element (Fig. 5B) so that not only the entire 
length of 40 bases is required for CDE activity, but also the specific sequence. This also 
excludes the possibility that the CDE is a class III-ARE, as in this case, the mutations in 
Om5 and Om6 would not have had any effect on CDE-mediated decay. 
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3.2 Nucleolin was identified as the CDE binding  
      protein
3.2.1 Identification of a specific CDE binding protein
To deepen our understanding of the mechanism underlying CDE-mediated decay, we decided 
to identify the trans-acting factors interacting with this cis-element. By UV-crosslinking 
experiments with the CDE-K, we were able to visualize a protein at approximately 60kD, 
named complex 1, that could be competed with a CDE but not with an ARE probe, indicating 
the specificity of the protein towards the CDE (Fig. 6). It was also of interest to test whether 
the CDE differs from its mutants with respect to protein binding and whether this correlates 
with the CDE-activity. This was tested by electrophoretic mobility shift assay. A low mobility 
complex A formed with the CDE and was still visible in the mutant Om2, but became 
progressively weaker with the other mutants. Mutant L showed only a low association with 
protein. One could speculate at this point that the affinity of the CDE-binding protein seemed 
to be higher for the CDE than for the mutants, which was proven in later experiments. 
3.2.2 Purification and identification of nucleolin
Encouraged by the binding results above, we tried to purify complex 1 CDE-binding activity. 
We chose different chromatography media, and assayed for the unbound protein under low 
or high salt conditions, which we were able to visualize by UV-crosslink experiments 
(Fig. 7). With blue and red sepharose matrices, the protein was bound even under high salt 
conditions, making them unsuitable for the purification procedure as elution from this matrix 
was not possible. Phenyl sepharose was also unsuitable as it was not able to bind complex 
1 at all. This left Q and heparin sepharose, which were both able to bind the activity under 
low salt but not under high salt conditions. We started to purify the binding activities over 
two affinity steps, initially with heparin sepharose (Fig. 9), which is able to adsorb proteins 
specifically binding to sugar residues, and an affinity matrix generated by linking the 
biotinylated CDE to streptavidin beads (Fig. 10), which should efficiently interact with the 
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CDE specific protein. After the affinity purification, the fraction was checked for its ability to 
bind to the CDE-fragment O, but not CDE-fragment L before proceeding further. By EMSA 
we observed that radioactive CDE-O, but not the CDE-L probe, was shifted confirming 
enrichment of the CDE-binding activity. However the observed complex was much smaller 
than complex A in Fig. 6. Due to the high grade of purification obtained after the affinity step 
by the harsh washing and elution steps, the protein complex A could have been disrupted 
and proteins not directly or strongly associated with the CDE may have been washed 
away. An alternative explanation could be proteolytic degradation of complex A during the 
purification procedure, giving rise to a higher mobility complex. One has to note that both 
the heparin and the affinity matrices are also weak cation-exchange matrices due to their 
negative charge, which allow for non-specific binding of positively charged proteins. To 
reduce the amount of the non-specifically binding proteins, we employed an anion exchange 
matrix in a final purification step to repel the positively charged proteins (Fig. 11). It has to 
be noted that the size of the complexes 1 and 2 appear to vary relative to the protein markers. 
One reason could be that different sets of markers were used in different experiments, which 
may cause the discrepancy between the complex 1 at 60kD as in Fig. 6 compared to 50kD 
in the other figures. Another possible reason could be the proteolytic degradation mentioned 
earlier. Furthermore, we also copurified with this procedure the protein-RNA complex 2, 
which was thought to bind non-specifically to the CDE as shown with the UV-crosslink 
competition assay in Fig. 6. 
Candidate CDE-binding proteins were identified by mass spectrometry (Fig 12). Besides 
the often encountered protein contaminant keratin, peptides were identified from the acidic 
protease cathepsin K, involved in osteoporosis reviewed in (Yamashita and Dodds 2000), the 
protein-chaperone GRP78, which helps in correctly folding of the tertiary structure of certain 
proteins (Ng et al. 1992), and the RNA binding protein nucleolin reviewed in (Ginisty et al. 
1999). Although only fragments of nucleolin and no full-length protein were identified, it 
appears the most likely candidate to be involved in CDE-binding. 
Using a similar approach, nucleolin and YB-1 were purified as interacting proteins of the jun-
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kinase responsive element (JRE). Here the two JRE-crosslinking activities at 50 (p50) and 
100kD (p100) were first purified over a anion exchange column, which separated p50 from 
p100. p100 was further purified via heparin sepharose and an affinity-RNA step, whereas 
p50 was gel-filtrated over Superose 6B and an affinity-RNA step (Chen et al. 2000). 
The various nucleolin bands that we identified could be divided into two groups. The first 
group, bands 2 to 5, contain peptides from the RRMs 1 and 2, and the second group from 
band 6 to 9, contain peptides from the RRMs 1 to 4 of nucleolin. Although the peptides 
identified from both groups respectively are similar, the sizes of the different bands vary 
greatly, from 30kD (band 2) to 40kD (band 5), or from 50kD (band 6) to 65kD (band 9). 
This size difference could be due to an extension on the N-terminal side, where no peptides 
could be identified by MALDI-ToF. Furthermore nucleolin was identified at the positions of 
complex 1 and complex 2 (Fig. 11), which was thought to bind non-specifically to the CDE 
and raises the question of how specific the CDE-nucleolin interaction really is. 
3.3 The chaperone GRP78 
GRP78/BiP is a chaperone associated with the endoplasmatic reticulum and is induced by 
inflammatory stress. It is involved in folding of secreted and membrane proteins (Ng et al. 
1992). No evidence has been found so far that it plays any role on proteins involved in RNA 
degradation, but interestingly it has been reported to display anti-inflammatory properties. 
It can be found as an autoantigen in patients suffering from rheumatoid arthritis, which is 
induced by TNFα as discussed before, and seems to counteract the inflammatory response 
by stimulation of macrophages to release anti inflammatory cytokines (reviewed in Panayi 
and Corrigall 2006).
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3.4 The multifunctional protein nucleolin
3.4.1 Structure of nucleolin
Nucleolin/C23, which was initially discovered in 1973 as a spot on a two-dimensional gel 
(Orrick et al. 1973; Prestayko et al. 1974) is a highly expressed protein and can constitute 
up to 10% of nucleolar protein (Bugler et al. 1982). Homologous proteins have been found 
in eukaryotes from yeast to man (Table 1). The human nucleolin gene is organized in to 
14 exons and 13 introns located on chromosome 2 (Srivastava et al. 1990). It consists of 
a highly acidic N-terminal domain separated by basic stretches (Fig. 12C) and is highly 
phosphorylated by different kinases (reviewed in Ginisty et al. 1999). The central part of 
nucleolin in higher animals contain 4 RNA recognition motifs (RRMs), through which 
Organism Name Mol. Mass RRMs References
Human Nucleolin 76.3 (100) 4 (Srivastava et al. 1989)
Mouse Nucleolin 76.7 (105) 4 (Bourbon et al. 1988)
Rat Nucleolin 77.1 (110) 4 (Bourbon and Amalric 1990)
Hamster Nucleolin 77.0 (100) 4 (Bourbon and Amalric 1990)
Chicken Nucleolin 75.6 4 (Maridor et al. 1990)
Xenopus laevis Nucleolin 75.52 (95)
72.20 (90)
4 (Caizergues-Ferrer et al. 1989; 
Rankin et al. 1993)
Alfalfa NucMs1 67.1 (95) 2 (Bogre et al. 1996)
Pea Nucleolin 64.8 (90) 2 (Tong et al. 1997)
Onion Nop64A
Nop61A
(64)
(61)
2 (de Carcer et al. 1997)
Arabidopsis 
thaliana
FMV3bp 57.9 2 (Didier and Klee 1992)
Tetrahymena 
thermophilia
Nopp52 51.7 2 (McGrath et al. 1997)
S. pombe gar2 53 2 (Gulli et al. 1995)
S. cerevisiae Nsr1p 44.5 (67) 2 (Lee et al. 1992)
Table 1. Nucleolin and nucleolin like proteins in several organisms. Apparent molecular masses given in 
brakets
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nucleolin is able to make specific contact to its RNA-target. The C-terminal domain contains 
many Arg-Gly-Gly (RGG) repeats, which are interspersed by other amino acids. The length 
of these RGG domains are not conserved between the species, and can bind to RNA in a non-
specific way due to the high positive charge (Ghisolfi et al. 1992). This region is methylated 
on the arginine residues (Lischwe et al. 1982), which is thought to counteract non-specific 
nucleolin binding. 
3.4.2 Localization of nucleolin
Nucleolin is ubiquitously expressed in most cells throughout the organism (Maridor et al. 
1990) and is mostly located in the nucleolus. For nuclear localization, the N-terminal domain 
contains a nuclear localization sequence. The nucleolar localization however is dependent 
upon nucleolin-RNA interaction (Schwab and Dreyer 1997), where the RGG domain in 
combination with at least one RRM is required as was shown by mutations in the RNA 
recognition motives (Creancier et al. 1993). By electron microscopy, it could be detected 
mostly in the dense fibrillar region of the nucleolus (Escande et al. 1985; Biggiogera et al. 
1990), and is relocalized during mitosis into cytoplasmic nucleolus-derived foci and pre-
nucleolar bodies (Gas et al. 1985; Dundr et al. 1997) that also contain other proteins involved 
in rRNA processing (Hernandez-Verdun and Gautier 1994). By heterokaryon assays, it was 
shown that nucleolin is also able to shuttle between the nucleus and the cytoplasm (Borer 
et al. 1989; Schmidt-Zachmann and Nigg 1993) and that the N-terminus of nucleolin is 
required for this, although it does not seem to be actively exported (Schmidt-Zachmann 
and Nigg 1993). Specific circumstances have been described, such as poliovirus infection 
(Waggoner and Sarnow 1998) or in rat IEC-6 cells grown without laminin (Yu et al. 1998), 
where nucleolin can relocalize to the cytoplasm in high amounts, while low levels of 
nucleolin always seem to be present in the cytoplasm.
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3.4.3 Functions of nucleolin
Nucleolin appears to be involved in many processes ranging from splicing to being a 
receptor on the plasma membrane (review in Ginisty et al. 1999). Here we only describe the 
functions most acknowledged in the field, namely ribosomal biogenesis and posttranslational 
regulation.
3.4.3.1 Ribosome biogenesis
Nucleolin is suggested to be involved in rRNA transcription, although no concrete evidence 
has yet been offered. All the studies suggesting this were based on in vitro experiments 
and even then, only correlations could be drawn between a functional role and the absence 
or presence of nucleolin (review in Ginisty, Sicard et al. 1999). In yeast, it could be 
demonstrated that the nucleolin homologues Nsr1p and gar2 (Table 1) are required for 
the correct processing of rRNA and disruption of the genes led to a deficit in production 
of 18S rRNA and 40S ribosomal subunits (Lee et al. 1992; Gulli et al. 1995). In mouse, 
nucleolin was implicated in the first step of pre-rRNA splicing. It was shown to bind co-
transcriptionally (Lazdins et al. 1997) to two sequence motifs in the rRNA, the NRE (Serin 
et al. 1996) and the ECM (Ginisty et al. 2001), and subsequently recruit the U3 snoRNP and 
other factors that promote rRNA processing in vitro (Ginisty et al. 1998). A very well studied 
aspect here is the interaction of nucleolin with the nucleolin recognition element (NRE). The 
NRE was discovered by a SELEX experiment as a hairpin with the conserved loop sequence 
(U/G)CCCC(A/G) (Ghisolfi-Nieto et al. 1996). This sNRE motif is bound specifically by the 
RRMs 1 and 2 of nucleolin (KD = 1-5 nM), as was shown by bandshift assays, NMR and 
biacore experiments (Allain et al. 2000a; Allain et al. 2000b; Finger et al. 2003; Finger et al. 
2004; Johansson et al. 2004), whereas the NRE-motifs from the 5’ETS region of mouse pre-
rRNA (b1NRE and b2NRE) only bound with a K
Ds
 of 1μM (Johansson et al. 2004). From 
these NMR studies it became clear that the RRMs 1 and 2 do not interact with each other and 
bind on opposite sides of the stem-loop formed by the sNRE and stabilizes it (Allain et al. 
2000a). In addition, the linker between RRM 1 and 2 seems to play a role in this interaction 
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(Finger et al. 2004). According to the data obtained by NMR, nucleolin is proposed to act as 
an RNA-chaperone (Allain et al. 2000a). The binding of nucleolin to the ECM is not well 
studied yet, but it is clear that this interaction requires all four RRMs of nucleolin (K
D
 = 
50nM) (Ginisty et al. 2001).
3.4.3.2 Post-transcriptional regulation
Besides the roles in rRNA maturation and ribosome biogenesis, nucleolin is implicated in 
several other processes. A few reports have shown nucleolin playing a role in regulation of 
mRNA stability and translation. For example nucleolin is suggested to be involved in the 
stabilization of the amyloid precursor protein (APP) mRNA. It was shown to bind, together 
with hnRNPC, to a 29 nucleotide long sequence that was responsible for degradation of 
the APP transcript (Zaidi and Malter 1995). Nucleolin is also associated with the 3’UTR of 
the human renin mRNA together with YB-1 and other proteins. Here the forskolin induced 
stabilization of the renin mRNA is correlated with increased levels of nucleolin, YB-1 and 
other partners associating to the renin 3’UTR (Skalweit et al. 2003). Nucleolin also seems to 
play a role in maintaining the stability of the β-globin mRNA. Nucleolin is reported to bind to 
the 3’UTR of endogenous β-globin by RNA-IP assays, and a model proposes that it facilitates 
the binding of the known stabilizing complex α-CP and so contributes to super stabilization of 
the β-globin mRNA (Jiang et al. 2006). A fourth case where nucleolin is involved in mRNA 
stabilization is for the anti-apoptotic gene bcl2. Nucleolin is reported to bind the ARE of bcl2 
(Sengupta et al. 2004), not to the AUUUA pentamers itself, but to a 50nt long intervening 
sequence (Eleanor Spicer, personal communication). It was shown by in vitro decay assays 
that extracts from okadaic acid stimulated cells can rapidly degrade a bcl2-ARE probe and the 
addition of a recombinant truncated nucleolin fragment (residues 284-707, corresponding to 
RRMs 1 to 4) inhibited this degradation. It was proposed in a model that the stimulation with 
okadaic acid and taxol led to fragmentation of nucleolin and thus enables the degradation 
machinery to destroy the unprotected bcl2 mRNA (Sengupta et al. 2004). It could also be 
shown that increased cytoplasmic localization of nucleolin correlates with bcl-2 stabilization 
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in chronic lymphoid leukemia (CLL) cells (Otake et al. 2006). Recently an RNA-aptamer 
has been developed for treatment in cancer patients having upregulated bcl2 levels. It could 
also be shown that increased cytoplasmic localization of nucleolin correlates with bcl-2 
stabilization in CLL cells. This aptamer inhibits the nucleolin-bcl2 mRNA interaction and 
leads to rapid degradation of this RNA in vivo. Fortunately, this aptamer does not interfere 
with ribosome biosynthesis because it is restricted to the cytoplasm allowing the in vivo 
biological effect to be ascertained (Daniel Fernandez, personal communications). Nucleolin 
was also implicated together with YB-1 in the stabilization of the IL-2 message. Both proteins 
were shown to associate with the JRE-sequence in the IL-2 5’UTR, but not to mutant motifs 
by UV crosslinking and immunoprecipitation experiments. It was demonstrated in a cell free 
system, that nucleolin and YB-1 are required for the stabilization of the IL-2 mRNA. When 
one or the other protein was depleted from the extracts, a JNK signal was not able to stabilize 
the IL-2 mRNA. Furthermore after anti-sense depletion of YB-1 or nucleolin, IL2 mRNA 
could no longer be stabilized by MEKK, and that over expression of nucleolin in N9 cells, 
which are unresponsive to MEKK induced stabilization of an IL-2 reporter, could restore the 
stabilizing action of MEKK (Chen et al. 2000).
In addition, nucleolin does not only seem to play a role in mRNA stabilization, but also 
in translational regulation of certain messages. It is claimed to enhance translation of the 
matrix metallo-protease 9 (Fahling et al. 2005), and in the translation suppression of p53 
(Takagi, Absalon et al. 2005). As nucleolin appears to perform many functions, it is therefore 
very important to rigorously prove a putative interaction of nucleolin, especially as reports 
have suggested that the RGG domain of nucleolin can interact with RNA non-specifically 
(Ghisolfi et al. 1992).
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3.5 The nucleolin-CDE binding is specific 
As stated above, the nucleolin-RNA association is not always sequence specific. Therefore 
we needed to demonstrate that nucleolin is binding specifically to the CDE-O by pull-down 
assays using biotinylated RNAs of the sNRE, the CDE-O and a 40nt stretch of RNA from 
the IL-3 3’-UTR as negative control. Unfortunately, we found that nucleolin associates 
with all three RNAs and is pulled down with equal efficiency (Fig. 13). To clarify the 
situation, we decided to perform further bandshifts comparing the CDE-O with L and the 
fragment O mutants. The experiments were performed in THP-1 human macrophages, as the 
commercially available antibodies capable of supershifting a nucleolin CDE complex only 
recognize human nucleolin. We could show that in THP-1 macrophage extracts a specific 
band is observed with the CDE-probe that is supershifted with an anti-nucleolin, but not 
with the GST-control antibody. This specific band is absent when the CDE-L probe or the 
other O-mutants are employed with the notable exception of mutant Om3, which still retains 
some nucleolin binding (Fig 14). The binding intensity of Om3 to nucleolin was however 
greatly reduced compared to CDE-O, whereas the non-specific activity was able to bind the 
probes in comparable amounts. It should be mentioned that fragment L associates poorly 
with nucleolin even when excessive amounts of radioactively labelled probe is used. This 
encouraged us to continue and concentrate on recombinant nucleolin, in order to further 
investigate the specificity of the nucleolin-CDE binding. Recombinant GST-nucleolin was 
produced using the baculovirus expression system (Fig. 15), and the purified GST-nucleolin 
fusion protein was capable of binding the NRE sequence only after cleavage of the GST-tag. 
To our knowledge this is the first production of functional recombinant full-length nucleolin, 
which is a rather refractory protein to express (Fig. 16). The recombinant nucleolin was 
able to bind the SELEX selected NRE, but not a mutant NRE containing two nucleotide 
substitutions (Johansson et al. 2004). It could also discriminate between the CDE-O probe 
and the mutant probes Om2 and L, which show greatly reduced binding to the recombinant 
nucleolin. With the full-length recombinant nucleolin, it was clear that CDE-O associates 
for better with nucleolin than any of its mutants. This result nicely correlates with the in 
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vivo decay activities of the CDE-O and mutant reporters, and argues that nucleolin might be 
involved in promoting constitutive decay of the TNFα-message.
To prove interaction of endogenous nucleolin with endogenous TNFα mRNA in vivo, we 
performed RNA-IP (Fig. 17). Using specific antibodies against nucleolin and HuR, we 
were able to pull down the respective proteins in sufficient amounts from LPS-stimulated 
and unstimulated THP-1 extracts as demonstrated (Lopez de Silanes et al. 2004a). HuR 
was previously shown to associate with the TNFα-ARE (Dean et al. 2001) and served as a 
positive control, whereas an anti-myc-epitope antibody that is not expected to interact with 
the TNFα mRNA was employed as a negative control. With the anti-HuR antibody, we were 
indeed able to co-immunoprecipitate detectable amounts TNFα mRNA, which was increased 
in LPS stimulated extract as HuR exits the nucleus and TNFα mRNA levels are increased 
upon LPS stimulation (Stoecklin et al. 2003). With the anti-nucleolin antibody, we were also 
able to precipitate the TNFα mRNA, but in much higher amounts, taking into consideration 
that the anti-nucleolin antibody was less efficient than the anti-HuR antibody. Furthermore 
we observed no contaminating mRNAs that were pulled down, unlike the case in many other 
publications. We conclude that nucleolin is directly interacting with the TNFα-mRNA in 
vivo, most probably with the CDE as suggested by EMSA in vitro. 
3.6 CDE mediated decay is influenced by nucleolin
As stated above, the binding of nucleolin to the CDE-O and its mutant sequences correlates 
exactly with the observed in vivo activity. The CDE-O reporter is rapidly degraded and 
binds nucleolin, whereas the mutant sequence containing reporters Om2, Om3, Om5 and 
L are stable and show greatly reduced nucleolin binding. To obtain evidence showing that 
nucleolin influences CDE-dependent decay, we down-regulated nucleolin by RNAi to10% 
of its original level by two rounds of transfection over 72h in a GFP-CDE reporter cell 
line. We could not observe differences in growth of the si-nucleolin transfected cells versus 
the control, although we were concerned that knockdown of nucleolin could interfere with 
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ribosomal biosynthesis and growth as was seen in the knockout of the Nrs1 and gar2 proteins 
in yeast (Lee et al. 1992; Gulli et al. 1995). Presumably 72 hours is too short to see an effect on 
growth from reduced amounts of ribosomes, in addition the knockdown was only up to 90%, 
perhaps leaving enough nucleolin to produce sufficient ribosomes. The GFP-reporter levels 
were analysed by FACS, where increased levels of GFP could be observed when nucleolin 
was down regulated compared to the controls. This increase of protein levels may be the 
result of different processes like transcriptional upregulation, translational enhancement or 
mRNA stability. Proceeding from our previous results, this we suggest that nucleolin might 
be involved in the destabilization of the GFP-CDE reporter, therefore the decay kinetics 
of the reporter after nucleolin siRNA treatment were analysed in several experiments. We 
observed that the decay activity of the CDE-reporter was indeed reduced after si-nucleolin 
treatment compared to the controls. When calculated, the reporter half-lives from si-treated 
cells significantly increased from 96 minutes (control) to 134 minutes (si-nucleolin treated 
cells). We can explain this modest effect by the fact that nucleolin is highly expressed, 
and that even after down regulation there might be sufficient nucleolin present to promote 
decay thereby preventing us from observing a stronger effect. Furthermore the cell line used 
contains the TNFα-CDE embedded in a β-globin UTR context, which was recently reported 
to be stabilized by nucleolin (Jian et al. 2006) and would counteract our effect. Another 
explanation would be that nucleolin functions as an RNA-chaperone on the CDE making 
it accessible for the degradation machinery. In this case we would also expect the effect to 
be small as RNA folding is a dynamic process, where nucleolin would only speed up the 
conformational changes required for degradation. 
To summarize the work presented in this thesis we propose the following working hypothesis 
(Fig. 20): Nucleolin is constitutively associated with the TNFα-CDE independently of LPS 
stimulation. When nucleolin is associated with the CDE, the CDE-bearing mRNA is degraded 
rapidly, most probably by enhanced deadenylation as was seen in the stably transfected 
NIH3T3 cells (Fig. 4D), although activation of other proteins of the decay machinery cannot 
be excluded. Based on RNAi experiments, and taking into consideration the other functions 
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of nucleolin in the cytoplasm such as stabilization of the IL-2 and bcl-2 mRNAs (Chen et 
al. 2000; Sengupta et al. 2004; Otake et al. 2006) or the translational inhibition of the p53 
mRNA (Takagi et al. 2005), we suggest that nucleolin needs to associate with an effector 
protein(s) (X) that efficiently induces CDE-mediated degradation. In order that nucleolin-
CDE binding only executes one of the many roles that nucleolin is capable of, the association 
between nucleolin and the factor X needs to be RNA dependent, and the associated protein 
would then be responsible for degradation.
3.7 Posttranscriptional regulation of TNFα mRNA  
      decay
The issue of regulation of TNFα mRNA expression in macrophages is very complex and 
involves many cis- and trans-acting factors (Fig. 21). We, among others, have found that 
endogenous TNFα mRNA in Raw 264.7 macrophages is unstable, and only minimal amounts 
FIG. 20. Working hypothesis of CDE-mediated decay. Nucleolin is constantly bound to the CDE and 
eventually recruits an unknown factor X, which is able to stimulate deadenylases (red fish).
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FIG. 21. Current model of the posttranscriptional regulation of the TNFα-mRNA.  For detailed 
description see text.
Discussion
88
Discussion
89
of TNFα protein is expressed (Han et al. 1990; Han et al. 1991; Stoecklin et al. 2003). It has 
been suggested that TNFα mRNA is degraded in unstimulated cells by the ARE-binding 
proteins TTP (Taylor et al. 1996) and AUF1 (Lu et al. 2006). TTP was reported to associate 
with components of the degradation machinery responsible for deadenylation, decapping 
and RNA body degradation (Lykke-Andersen and Wagner 2005), but the mode of action 
of AUF1 remains unclear. Furthermore it was demonstrated in knock out mice that TIA-1 
inhibits translation of TNFα in unstimulated cells (Piecyk et al. 2000).
Another element involved in TNFα mRNA decay is the CDE, which causes rapid decay of 
a reporter bearing this element (Stoecklin et al. 2003). We found that nucleolin is associated 
with the CDE and might also play a role in TNFα mRNA degradation by a yet unknown 
mechanism. We hypothesise that nucleolin associates with an unknown factor X or even 
with factors responsible for ARE-mediated decay like TTP or AUF1 and thus induces TNFα 
mRNA decay. 
In macrophages stimulated by LPS, the issue of TNFα mRNA stability is controversial. It is 
unclear whether AUF1 remains associated with the TNFα mRNA after LPS stimulation, but 
there is general agreement that TTP and TIA-1 dissociate from the TNFα ARE (Anderson et 
al. 2004), and are replaced by the stabilizing protein HuR (Dean et al. 2001). Some reports 
suggest that the TNFα mRNA is stabilized hereafter (Han et al. 1991; Brook et al. 2000; 
Stoecklin et al. 2004; Hitti et al. 2006) while others state that it remains unstable (Han et al. 
1991; Brook et al. 2000). In our hands the TNFα mRNA remains unstable even after LPS 
stimulation through the ARE-independent action of the CDE (Stoecklin et al. 2003). We 
suggest that nucleolin is constantly associated with the CDE and hypothesize that it helps 
a factor X in recruiting the decay machinery to the TNFα mRNA thereby overriding the 
stabilizing action of HuR.
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3.8 Outlook
The work presented in this thesis provides insight into the mechanism of CDE-mediated 
TNFα mRNA degradation via nucleolin binding but at the same time raises further questions 
which will be addressed in the future. The model in Fig. 21 displays the complexity of 
posttranscriptional regulation of the TNFα mRNA, and the function of the CDE has to 
be  evaluated further. Among the outstanding remaining questions are: Which degradation 
pathway is activated by the CDE? Can the CDE-mediated decay be influenced by external 
signals? What other factors are involved? Is there an interplay between the ARE and the 
CDE? 
By further characterizing the CDE and its interaction with nucleolin, hopefully we will learn 
more about CDE-mediated decay and the very complex posttranscriptional regulation of the 
TNFα mRNA. 
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4. Materials and Methods
4.1 Solutions
4.1.1 Cell culture media
M2 Medium Iscove’s Modified Dulbecco’s Medium (IMDM), 
10% fetal calf serum (FCS), 50μM 2-mercapto-
ethanol, 2mM glutamine, 100U/ml penicillin and 
100μg/ml streptomycin.
Phosphate Buffered Saline (PBS) 10mM Phosphate buffer pH 7.4, 2.7mM KCl, 
137mM NaCl
Propidium iodide solution 5μg/ml propidium iodide in PBS
Luria-Bertani Medium (LB) 20g Lennox L Broth base (Invitrogen) in 1000ml 
H
2
O dist.
Autoclave 20min at 120°C
LB-Amp 100μg/ml ampicillin in LB
LB-Kan 25μg/ml kanamycin in LB
LB-Agar 20g LB Broth base, 15g Select Agar in 1000ml H
2
O 
dist. 
Autoclave 20min at 120°C, cool down and add the 
appropriate antibiotic and pour the plates
Baculo select agar plates LB agar containing 50μg/ml kanamycin, 7 μg/ml 
gentamycin, 10 μg/ml tetracycline, 100 μg/ml Bluo-
gal, 40 μg/ml IPTG
4.1.2 Solutions for SDS-gel electrophoresis and western blotting
10x SDS running buffer 250mM Tris HCl pH 7.5, 2.5M Glycine, 1% Sodium 
Dodecylsulfate (SDS)
5x Sample buffer 250mM Tris HCl pH 6.8, 500mM Dithiothreithol 
(DTT), 0.1% Bromophenol Blue, 50% Glycerol
Blotting buffer 1x SDS running buffer, 20% Methanol
TBS (Tris buffered saline) 50mM Tris HCl pH 7.5, 150mM NaCl
TBST add 0.1% Tween-20 to TBS
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TBST Blocking buffer add 2% blocking Agent (Amersham-Pharmacia) to 
TBST
Western blot stripping solution 62.5mM Tris/HCl pH 6.7, 2% SDS, 100mM 2-
mercaptoethanol
SDS-Gel fixing solution 45ml Methanol, 45ml H
2
O, 5ml acetic acid
Coomassie stain solution 0.25mg Coomassie Brilliant Blue R-250 (Fluka), 
45ml Methanol, 45ml H
2
O dist., 10ml Acetic acid
Sensitizing solution 0.02% Na
2
S
2
O
3 
in H
2
O
AgNO
3
 solution 0.1% AgNO
3
 in H
2
O
Developer 12.5g Na
2
CO
3
, and 150μl formaldehyde in 500ml 
H
2
O
4.1.3 Solutions for DNA Gel electrophoresis
50x TAE buffer 242g Tris base, 57.1ml Acetic acid, 18.6g EDTA
5x DNA Loading buffer 0.25% Bromophenol blue, 0.25% Xylene cyanol FF, 
15% Ficoll Type 400 (Pharmacia)
4.1.4 Solution for RNA preparation and northern blotting
Solution I (Lysis buffer) 10mM Tris HCl pH7.5, 150mM NaCl, 1.5mM 
MgCl
2,
 0.65% NP-40
Solution II (Extraction buffer) 10mM Tris HCl pH7.5, 10mM EDTA pH8, 350mM 
NaCl, 1% SDS, 7M Urea: store in the dark at room 
temperature
10x MOPS buffer 41.8g 4-Morpholinepropane-sulfonic acid (MOPS), 
6.8g Na-Acetate·3 H
2
O, 20ml 0.5M EDTA in 
1000ml H
2
O dist.
2x RNA loading buffer 7.2ml Formamide, 1.6ml 10xMOPS buffer, 2.6ml 
Formaldehyde (37%), 1.8ml dMilliQ H
2
O, 1ml 80% 
Glycerol (in H
2
O), 100μl 1% Bromphenol blue, 
14μl Etidium Bromide (Sigma): store at –20°C
Gel solution 1.5% Agarose, 1x MOPS, 1% Formaldehyde
20x SSC 3M NaCl, 0.4 M Trisodiumcitrate, pH 7.0
50x Denhardt’s solution 1% Ficoll, 1% Polyvinylpyrolidine, 1% BSA
Hybridization buffer (DNA pro-
be)
500mM Sodium phosphate buffer pH 7.2, 7% SDS, 
1% BSA, 2mM EDTA
Hybridization buffer (RNA probe) 50% formamide, 5x SSC, 5x Denhardt’s, 5mM 
EDTA, 10mM PIPES pH 6.4, 0.4g/ml yeast RNA, 
1x SDS
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Northern stripping buffer 0.5% SDS in H
2
O
4.1.5 Solutions for UV cross-linking assays
10x DNK buffer 500mM Tris/HCl pH 7.8, 25mM MgCl
2
, 1mM 
EDTA, 50mM DTT, 10mM spermidine
Gel elution buffer 0.5M Ammonium acetate, 10mM Magnesium 
acetate, 1mM EDTA, 0.1% SDS
5x Reaction buffer 20mM Hepes pH 7.4, 6mM MgCl
2
, 2mM DTT, 
200mM KCl, 12% Glycerol, 6.5mM ATP, 25mM 
Creatine Phosphate
Dilution buffer 10mM Hepes pH 7.4, 3mM MgCl
2
, 1mM DTT, 
100mM KCl, 6% Glycerol
4.1.6 Solutions for RNA-EMSA
5x EMSA buffer 50mM HEPES/NaOH pH7.6, 15mM MgCl
2
, 200mM 
KCl, 25% Glycerol, 10mM DTT 
EMSA lysis buffer 10mM HEPES/NaOH pH7.6, 3mM MgCl
2
, 40mM 
KCl, 5% Glycerol, 2mM DTT, 0.5% NP-40 and 1x 
complete protease inhibitor (Roche)
10x Bandshift buffer (BSB) 450mM Tris-borate pH8.0
EMSA running buffer 45mM Tris-borate pH8.0 and 0.05% TritonX-100
4.1.7 Buffers for Chromatography
Hypotonic Lysis buffer 10mM KCl, 2mM MgCl2, 1mM EDTA, 1mM 
EGTA, 1x complete protease inhibitors (Roche), 
1mM PMSF, 1mM NaF, 0.4mM Na
3
VO
4
Buffer A 50mM Tris pH 8.0, 2mM MgCl
2
, 1mM DTT, 6% 
glycerol
Buffer B 50mM Tris pH 8.0, 1M KCl, 2mM MgCl
2
, 1mM 
DTT, 6% glycerol
GST-Wash buffer 10mM PBS pH 7.4, 2mM MgCl
2
 and 0.2% Triton 
X-100
GST-Wash buffer 500 PBS pH 7.4, 2mM MgCl
2
 and 0.2% Triton X-100, 
500mM NaCl
TeV-buffer 50mM Tris/HCl pH 8.0, 0.5mM EDTA, 1mM DTT
Materials and Methods
92
Materials and Methods
93
4.1.8 Solutions to prepare cellular protein extracts
Hypotonic Lysis buffer 10mM KCl, 2mM MgCl
2
, 1mM EDTA, 1mM EGTA, 
1x complete protease Inhibitors (Roche), 1mM 
PMSF, 1mM NaF, 0.4mM Na
3
VO
4
RIPA lysis buffer 10mM Sodium phosphate buffer pH 7.2, 150mM 
NaCl, 1% Triton X-100, 1% Sodium desoxycholate, 
0.1% SDS, 1x complete protease inhibitors (Roche)
Extraction buffer 25mM Tris pH 8.0, 2mM MgCl
2
, 0.1% Triton X100
4.1.9 Solutions for RNA-IP
RNA-IP lysis buffer 100mM KCl, 5mM MgCl
2
, 10mM Hepes/KOH, pH 
7.0, 0.5% Nonidet P-40
Add at the time of use:
1mM DTT, 100units/ml RNaseIn (Promega), 0.2% 
Vanadyl ribonucleoside complexes (VRC) (Sigma), 
0.2mM PMSF, 1x Complete Inhibitor cocktail 
(Roche)
NT2-buffer 50mM Tris/HCl, pH 7.4, 150mM NaCl, 1mM 
MgCl
2
, 0.05% Nonidet P-40
4.1.10 Cell lines and bacterial strains
Mammalian cell lines
HT1080 Human fibrosarcoma cell line
HT1080 GFP-E2 HT1080 containing the MXh GFP-TNFα element II 
construct
Raw 264.7 Mouse macrophages 
THP-1 Human macrophages
B2A2 Mouse fibroblast cell line derivative of NIH 3T3 
cells expressing a tetracycline repressor (Xu, Loflin 
et al. 1998)
B2A2 -O B2A2 cells stably transfected with pMXb-O plasmid
B2A2 -L B2A2 cells stably transfected with pMXb-L plasmid
HEK 293 Human embryonal kidney cell
Insect cell lines
High 5 Invitrogen
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Bacterial strains
DH5a Invitrogen
DH10 bac Invitrogen
4.1.11 Primers
Primers for cloning
TV242 5’-GATCGACCCAGTGTGGGAAGCTGTCTTCAGACAGACATG
TTTTCTGTGAAAACGGAGCTGAGCTG-3’
TV243 5’-GATCCAGCTCAGCTCCGTTTTCACAGAAAACATGTCTGTC
TGAAGACAGCTTCCCACACTGGGTC-3’
TV246 5’-GATCCTTCAGACAGACATGTTTTCTGTGAAAACGGAGCTG
AGCTG-3’
TV247 5’-GATCCAGCTCAGCTCCGTTTTCACAGAAAACATGTCTGTC
TGAAG-3’
Om2 5’-GATCAGGAAGACAGACATGTATAGTCCGAAAACGGAGCT
GAGCTG-3’
Om2AS 5’ GATCAGCTCAGCTCCGTTTTCGGACTATACATGTCTGTCT
TCCTG-3’
Om3 5’-GATCAGGAAGACAGACATGTTTTCTGTGAAAACGGAGCTG
AGCTG-3’
Om3AS 5’-GATCAGCTCAGCTCCGTTTTCACAGAAAACATGTCTGTCTT
CCTG-3’
Om5 5’-GATCCTTCAGATGTTTTCTGTGAAAACGGAGCTGAGCTG-3’
Om5AS 5’-GATCAGCTCAGCTCCGTTTTCACAGAAAACATCTGAAGG-
3’
Om6 5’-GATCCTTCAGACAGACATGTTTTCTGTGAAAACGGAGG-3’
Om6AS 5’-GATCCTCCGTTTTCACAGAAAACATGTCTGTCTGAAGG-3’
M2138 5’-GATCCTCTATTTATATTTGCACTTATTATTTATTATTTATTT
ATTATTTATTTATTTGA-3’
M2139 5’-GATCTCAAATAAATAAATAATAAATAAATAATAAATAATA
AGTGCAAATATAAATAGAG-3’
M2354 5’-GATCCAGACTGTTTTCTGTGAAAACGGAGCTGA-3’
M2355 5’-GATCTCAGCTCCGTTTTCACAGAAAACATGTCTG-3’
TV250 5’-AATTCAGATTACGATATCCCAACGACCGAAAACCTGTATTT
TCAGGGCAG-3’
TV251 5’-GATCCTGCCCTGAAAATACAGGTTTTCGGTCGTTGGGATAT
CGTAATCTG-3’
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Nucleolin-
baculo
5’-GAAGATCTCTATGGTGAAGCTCGCAAAG-3’
Nucleolin-
AntiS
5’-GCTCTAGACTATTCAAACTTCGTCTTCTTTCC-3’
Primers for sequencing
pSP73-100 5’-GAGCAGATTGTACTGAGAG-3’
M2016 5’-GTGCTGGTTATTGTGCTG-3’
GST 5’-GGTGATCATGTAACCCATCCTG-3’
NCL-1 5’-GTACCAACGCTTTTGCTTGTGC-3’
NCL-2 5’-GCACAAGCAAAAGCGTTGGTAC-3’
NCL-3 5’-GCAGAAGATGATGATGAGGAAG-3’
NCL-4 5’-GGAAGAAAAGCAGGGGGGCAGAA-3’
NCL-5 5’-CCTTAAAAGAATCATTTGAGGGC-3’
Primers for probe preparation
SP6-sNREs 5’-ATTTAGGTGACACTATAGAAGAGGAAATCCCGAAGTACTC-
3’
SP6-sNREa 5’-GAGTACTTCGGGATTTCCTCTTCTATAGTGTCACCTAAAT-3’
SP6-
NS26A18Cs
5’-ATTTAGGTGACACTATAGAAGAGGAAAGCCCAAAGTCCTC
-3’
SP6-
NS26A18Ca
5’-GAGGACTTTGGGCTTTCCTCTTCTATAGTGTCACCTAAAT-3’
M2353 5’-ACAGTCCATGCCATCACTGC-3’
M1170 5’-ACTGTGTTGGCATAGAGGTC-3’
M1171 5’-ACATCAAAGAGAAGCTGTGC-3’
Primers for PCR
BR5 5’-CACCACTTCGAAACCTGG-3’
BR6 5’-CAATGAGTGACAGTTGGTCAC-3’
BR16 5’-GATGCAATAACCACCCC-3’
BR17 5’-GAGGTAAGCCTACACTTTCCAAG-3’
BR18 5’-GAAGCTTCCATTCCAAGC-3’
BR19 5’-GCAACTTCCATCTCCTGG-3’
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M2352 5’-TGATGGTACATGACAAGGTGC-3’
M2353 5’-ACAGTCCATGCCATCACTGC-3’
Biotinylated RNAs for pulldown and affinity purification
CDE-K Bio-5’-UUAUGAAUGUAUUUAUUUGGAAGGCCGGGGUGUCC
UGGAGGACCCAGUGUGGGAAGCUGUCUUCAGACAGACAUC
UUUUCUGUGA-3’
CDE-O Bio-5’-CUUCAGACAGACAUGUUUUCUGUGAAAACGGAGCU
GAGCU-3’
sNRE Bio-5’-AGGCCGAAAUCCCGAAGUAGGCC-3’
IL-3-UTR Bio-5’-GAUGUGAGUACUGGGGCCAUGUUCAUUUGU-3’
siRNAs
BRF1/1s 5’-CAAGAUGCUCAACUAUAGAUU-3’
BRF1/1a 5’-UCUAUAGUUGAGCAUCUUGUU-3’
HuR1s 5’-CUACCUCCCUCAGAACAUGUU-3’
HuR1a 5’-CAUGUUCUGAGGAGGUAGUU-3’
NCL-2s 5’-GAAAUAAAGUUACCUUGGAUU-3’
NCL-2a 5’-UCCAAGGUAACUUUAUUUCUU-3’
NCL-3s 5’-GAAAGAAGACGAAGUUUGAUU-3’
NCL-3a 5’-UCAAACUUCGUCUUCUUUCUU-3’
4.2 Methods
4.2.1 Plasmid construction 
puroMXβglobin, puroMXβ-TNF-α-K and puroMXβ-TNF-α-L
Vectors were described previously (Stoecklin et al. 2003).
pSP73-K
This vector was constructed by Min Lu by inserting a PCR fragment of CDE-K into the 
pSP73 vector (Min Lu, unpublished data).
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FIG. 23. The pSP73 vector (Promega). All fragment for probe production were cloned into the BglII-site in 
front of the SP6 promotor.
FIG. 22.Vector map of  the puroMXβglobin vector.
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Vectors for CDE-mapping experiments
To generate the β-globin reporter constructs and the pSP73 constructs for probe preparation, 
3μg of the vector puroMXβglobin (Fig. 22) or pSP73 (Fig. 23; Promega) was linearized 
BglII (NEB), and subsequently gel purified. To phosphorylate and anneal the oligomers for 
the inserts, 100pmol of complementary DNA-oligomers were mixed and incubated with 
10U polynucleotide kinase (NEB) in the corresponding buffer containing 0.2mM ATP for 
1h at 37°C and subsequently heated to 95°C for 5min and cooled down slowly. Equimolar 
amounts of cut plasmid and insert were used for ligation with the Quick ligation kit (NEB) 
following the manufacturers protocol. The following DNA-oligomers were used: 
puroMXβ-TNF-α-M pSP73 TV242 TV243
puroMXβ-TNF-α-O pSP73-O TV246 TV247
puroMXβ-TNF-α-Om2 pSP73-Om2 Om2 Om2AS
puroMXβ-TNF-α-Om3 pSP73-Om3 Om3 Om3AS
puroMXβ-TNF-α-Om5 pSP73-Om5 Om5 Om5AS
puroMXβ-TNF-α-Om6 pSP73-Om6 Om6 Om6AS
puroMXβ-TNF-α-L pSP73-L M2354 M2355
pSP73-ARE M2138 M2139
pFastbacGST-TeV-Nucleolin
The murine nucleolin gene was amplified from cDNA with the primers nucleolin-baculo 
and nucleolin-AntiS. The PCR-product was cut with 20U of the restriction enzymes BglII 
and XbaI (NEB) and gel purified; 3μg of the pFastbacGST vector (Brondani et al. 2005) was 
cut with 20U EcoRI and XbaI (NEB) and the oligonucleotide sequences TV250 and TV251, 
which possess compatible ends for the EcoRI and BglII cutting sites, were phosphorylated 
and annealed as described above. Subsequently equimolar amounts of the three fragments 
were ligated using the Quick ligation kit (NEB). 
All plasmids created were positively selected by colony PCR and confirmed by 
sequencing.
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4.2.2 Transformation of E.coli
Ligation reactions or 40 to 100ng of pure plasmid were incubated with 50μl of competent 
DH5α E.coli (Invitrogen) cells for 20 min on ice and subsequently heat shocked for 2 min 
at 42°C. The bacteria were allowed to recover for 30 minutes in 450μl LB medium at 37°C 
and afterwards collected by centrifugation. The supernatant was removed leaving only 50μl, 
which were then streaked on LB-Amp plates and incubated overnight at 37°C.
4.2.3 Colony PCR of transformants
Colonies were picked with a sterile pipette tip and diluted in 25µl H
2
O. The tip was afterwards 
transferred in a correspondingly labeled culture tube containing LB-Amp selective medium. 
A PCR Master Mix (1x PCR Buffer (Qiagen), 0.2mM dNTPs each (Roche), 400nM primer 
pSP73, 400nM specific reverse primer (see table primers), 0.2U Taq Polymerase (Qiagen) in 
a total volume of 25μl) was prepared and added to each diluted colony. 
PCR-program: The bacteria were lysed for 5min at 94°C. 25 cycles with 30sec denaturation 
at 94°C, 30sec annealing at 50°C and 30sec extension at 72°C were performed. As a final 
cycle, 5min extension at 72°C was added then ramped to 4°C. 10µl of each extension product 
was loaded on a 3% NuSieve agarose (Sigma) gel to identify transformants with the correct 
insertion. The inoculated colonies of positive transformants were incubated overnight at 
37°C. 
4.2.4 Isolation of plasmid DNA
Gel purification
The gel slice of interest was cut out of the gel, and the DNA was extracted using the 
QIAquick Gel extraction kit (Qiagen) following the manufacturers protocol. The DNA was 
eluted in 30μl of H
2
O.
Miniprep 
4ml of LB-AMP medium was inoculated with an E.coli colony and grown for 12h to 
14h at 37°C. The bacteria were transferred in a 1.5ml Eppendorf tube and collected by 
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centrifugation in a tabletop centrifuge at 11000g for 30sec. The plasmid was isolated using 
the QIAprep spin Miniprep kit (Qiagen) following the manufacturers protocol. 
Maxiprep
One colony with the correct sequence was inoculated into 250ml of LB-Amp selective 
medium and incubated overnight at 37°C. The cells were pelleted by centrifugation in a 
Sorvall RC3C centrifuge (rotor 19) at 3500rpm for 20min. Plasmid extraction was performed 
following the QIAGEN Plasmid Maxi Kit protocol and DNA was dissolved in 400µl of TE 
buffer (Qiagen). The concentrations of the plasmids were determined by measuring the 
OD
260
 in a quartz cuvette before storing at -20°C.
4.2.5 Sequencing
The plasmids were sequenced using the ABI Prism 310 Genetic Analyzer (Applied 
Biosystems) or the CEQ 8000 (Beckman Coulter). The sequencing reaction was performed 
according to the manufacturers protocol. The pFastbac GST-TeV-nucleolin vector was 
sequenced with the primers GST, NCL-1, NCL-2, NCL-3, NCL-4 and NCL-5, the puroMXβ-
TNF-α with M2016, and the pSP73 constructs with the pSP73-100 primers.
4.2.6 Cell culture and transfection
Cell culture
All mammalian cell lines were grown in M2 medium with regular medium change. Adherent 
cells were split 1:5 every second day. Suspension cells were diluted 1:3 every second day.
High5 insect cells were grown at room temperature in JX-400 medium in a spinner culture. 
For transfection, the cells were plated at 90% density into a F-25 bottle. The cells adhered to 
the dish within 20min after plating and were ready for transfection.
Transfection of mammalian cells
Plasmids were transfected into cells with Lipofectamine 2000 reagent (Invitrogen) according 
to the manufacturers instruction.
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To obtain stable integration of puroMXβ-TNFα constructs into NIH3T3 B2A2 cells, the 
positive clones were selected by addition of 1μg/ml puromycin. Expression was tested by 
northern blot. 
Transfection of High5 insect cells
High5 cells were transfected with 10μl of the bacmid DNA and 10μl cell Fectin (Invitrogen). 
Both reagents were individually diluted in 500μl FX-400 medium and then mixed. The 
transfection reaction was added to a F-25 bottle of High5 cells in 1ml medium. The cells 
were incubated for 4 hours at 28°C followed by medium change. Two days after transfection 
the baculovirus containing supernatant was collected and stored at 4°C.
Transfection of siRNA
To downregulate nucleolin, HuR and BRF1 by siRNA, a 90% confluent 15 cm dish of 
HT1080 GFP-E2 cells was washed with Optimem (Invitrogen), and 8ml of Optimem 
was added afterwards. 200μl of Lipofectamine 2000 (Invitrogen) was diluted in 4ml 
Optimem and in a separate vial, 200μl of a 20μM solution of the corresponding siRNA 
was added to 4ml Optimem. The Lipofectamin 2000 and siRNA dilutions were mixed and 
after incubation for 20min, the solution was added dropwise to the cells. After exactly 4h 
incubation time the transfection mix was removed and fresh M2 medium was added. 24h 
after the first transfection, the cells were transfected again in the same manner. 48h after the 
first transfection the cells were split into three 10cm dishes for decay assay and one 6 well 
for FACS analysis. 
4.2.7 Propidium iodide staining and flow cytometry (FACS)
The cells were trypsinized, washed with PBS and collected by centrifugation. The cells were 
resuspended in a 5μg/ml propidium iodide solution. The samples were analyzed using the 
FACScan and Cellquest software (Beckton Dickinson).
Materials and Methods
102
Materials and Methods
103
4.2.8 Western blotting
10μg of complete cell lysate or 100ng of the recombinant protein were resolved on a Tris-
Glycine-Gradient-Gel 4-20% (Anamed). Immobilon-P membranes (Millipore) were prepared 
for blotting by rinsing with methanol and rehydrating them for 5min in H
2
O. Blotting was 
performed in 1x blotting buffer for 1h at 80V in a mini-blot apparatus (BioRad). After 
blotting the membrane was incubated in TBST blocking buffer for 1h on a shaker to reduce 
unspecific antibody binding. Membranes were incubated with the appropriate antibody 
overnight at 4°C or 1h at room temperature on a shaker. Membranes were rinsed and 
washed 3x with TBST for 30min. As a secondary antibody, horseradish-peroxidase-coupled 
goat anti-mouse antibody (DAKO) or goat-anti-rabbit antibody (Southern Biotechnology 
Associates) in blocking agent were added and membranes were incubated for 45min at 37°C. 
Membranes were washed as described above. To detect the specific signal, ECL reagent 
(Amersham Pharmacia) was added to the blot, which was then exposed to autoradiographic 
film (Hyperfilm MP, Amersham Pharmacia). 
For directly horseradish-peroxidase-coupled rabbit-anti-GAPDH antibody (Abcam), the 
incubation time was 45min at room temperature, followed by washing and exposure to 
film.
For stripping and reprobing of western blots, the membrane was incubated for 30min at 50°C 
in stripping solution. The blot was washed subsequently 4 times for 10min with TBST and 
blocked with TBST-blocking buffer.
4.2.9 RNA preparation
Isolation of cytoplasmic RNA
To prepare cytoplasmic RNA, cells were washed with PBS, trypsinized, collected in 10ml 
M2 medium and centrifuged at 1000g for 5min. The cell pellet was resuspended in 400μl 
ice-cold solution I and transferred to an Eppendorf tube. Cells were vortexed and centrifuged 
at 10000g for 1min at 4°C. The clear lysate was carefully transferred to a previously 
prepared Eppendorf tube containing 400μl solution II and 400μl of phenol/chlorophorm/
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isoamylalcohol (25:24:1) at 4°C. Tubes were vortexed vigorously (the solution gets cloudy 
and white), incubated for 10min at 65°C and centrifuged at 10000g for 20min at room 
temperature. The upper (aqueous) phase was carefully transferred to a new Eppendorf tube.
After incubating samples for ≥2h at –20°C, 800μl isopropanol was added to precipitate 
the RNA. Tubes were centrifuged at 10000g for 20min at 4°C. The white RNA pellet 
was carefully washed once with 500μl 80% ethanol. Residual ethanol was removed by 
evaporation in a speed vacuum centrifuge for 5-10min. The RNA pellet was dissolved in 
50μl RNAse free H
2
O for 10min at 65°C. To determine the RNA concentration, OD
260
 of 1:
400 diluted samples was measured and calculated accordingly: 1 OD
260
 corresponds to  
40μg/ml RNA. 
Isolation of total RNA
Total RNA was isolated using the RNeasy kit (Qiagen) following the manufacturers 
instructions.
4.2.10 RNA analysis by northern blotting
Sample preparation
To analyze RNA levels of specific transcripts, 25 to 40μg of RNA were diluted in 20μl 
RNAse free H
2
O and 2x RNA loading buffer was added to each sample at an equal volume. 
The samples were heated for 20min at 65°C before loading them onto the gel. The RNA 
was separated by electrophoresis in a 1.8% agarose MOPS gel. The RNA was transferred 
overnight onto a Hybond N+ membrane (Amersham Pharmacia) by capillary force using 
20x SSC. The membrane was rinsed with 0.1x SSC, 0.1% SDS, and crosslinked at 1200 
μJ/cm2.
Probe preparation
RNA-probes
Probes for fragment K: pSP73 K vector was cut with BglII, and the probe was transcribed 
from 100μg/ml template DNA in 40μCi α[32P] UTP, 500μM CTP, 500μM ATP, 500μM GTP- 
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and 20U of T7 RNA-polymerase (Promega).
Probes for β-globin were generated by SP6 transcription from the pSP73-β-globin vector 
linearized with EcoRI (Stoecklin, Lu et al. 2003). 
DNA-probes 
The template for the β-actin probe was generated by PCR-amplification of actin from 
cDNA with the primers M1170 and M1171, and for GAPDH with the primers M2352 and 
M2353. The puromycin N-acetyltransferase (puro) probe was generated by amplification of 
the puromycin gene from pBABE puro as described in (Stoecklin et al. 2001). The probes 
were generated from 25ng template DNA in 40μCi [32P]dCTP, 500μM dATP, 500μM dGTP, 
500μM dTTP- and 20U of Klenow fragment in the corresponding buffer (Promega), using 
1mM of the primers M1171 for the β-actin probe, M2353 for the GAPDH probe and random 
hexamers for the puro probe.
Hybridization
The membrane was blocked in hybridization buffer for at least 30min at 65°C for DNA 
probes in DNA hybridization buffer, and for RNA probes in RNA hybridization buffer 
at 55°C. After blocking the membrane, the appropriate probe was added and hybridized 
overnight at the indicated temperature. Blots hybridized with RNA probes were washed 
30min with 2xSSC, 0.2%SDS, 30min with 0.2xSSC, 0.2%SDS and 30min with 0.1xSSC 
and 0.1%SDS at 65°C. Solutions were prewarmed to 65°C. 
Blots hybridized with DNA probes were washed two times 20min with 2xSSC, 0.2%SDS and 
once 10 min with 0.1xSSC and 0.1%SDS at 42°C. The blots were exposed to phosphorimager 
plates (Biorad), and read out in the Personal Molecular Imager FX (Biorad).
4.2.11 UV-Crosslinking assay
Preparation of protein extracts
Raw 264.7 mouse macrophages were stimulated for 2h with 5μg/ml LPS and harvested 
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by centrifugation at 1500 rpm for 3min and washed once with ice-cold hypotonic lysis 
buffer. Cells were resuspended in 3 volumes of ice-cold hypotonic lysis buffer containing 
1x Complete protease inhibitor mix, 1mM NaF, 1mM NaVO
4
, 1mM PMSF and incubated 
for 10min on ice. Cells were snap frozen in liquid nitrogen, thawed at room temperature 
and disrupted in a dounce homogenizer by 30 strokes. The nuclei were centrifuged down at 
600g for 5min. The cytoplasmic supernatant was transferred to a new tube and cleared by 
centrifugation at 14000g for 20min. The cytoplasmic lysate was supplemented with 10% 
glycerol and 100mM KCl and frozen at –80°C until required.
Preparation of 4-thio-UTP
To phosphorylate 4-thio-UDP, 10mM 4-Thio-UDP (Sigma), 20mM GTP were incubated 
with 5 units nucleoside-5’-diphosphate kinase (Sigma) in 1x DNK-buffer for 2h at room 
temperature in the dark. The reaction was stopped by adding 5mM EDTA and 0.1% SDS, 
and the enzyme was digested with 1mg/ml proteinase K at 37°C for 15min. The reaction 
was adjusted to 500μl with 0.1%SDS solution and 1/10 volume of Na-acetate was added. 
After phenol extraction with 1 volume of phenol, the nucleotides were precipitated with 
1 volume of ethanol/acetone (1:1) for 30min at –20°C. The nucleotides were collected 
by centrifugation at 18000g for 30min at 4°C, dried in a speedvac and resuspended in an 
appropriate volume of nuclease free water. Approximately 50% of the 4-thio-UDP solution 
was converted to 4-thio-UTP (4-thio-UTP/GTP mix). The solution must be permanently 
kept in the dark all the time.
In vitro transcription of UV-Crosslinking probes
For this reaction 100μg/ml template DNA, 40μCi α[32P]ATP, 500μM CTP, 50μM ATP, 
500μM 4-thio-UTP/GTP-mix, 20U RNasin (Roche) and 20U of SP6 RNA-polymerase were 
mixed in 1x transcription buffer (Roche) and incubated for at least 2h at 37°C. Template 
DNA was removed by adding 10μg/ml DNAse RQ1 (Promega) for 15min at 37°C. 1/10 
volume of Na-acetate and 20μg tRNA were added to the reaction and extracted with 1 
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volume of phenol/chloroform/isoamyl alcohol (25:24:1). The probe was precipitated with 
3 volumes of ethanol at –20°C for at least 20min and centrifuged at 18000g for 20min. The 
pellet was washed once with 80% ethanol and dried down in the speedvac. 
Probe purification
The sample was resuspended in 10μl RNA loading buffer at 65°C for 5min and afterwards 
purified over a 5% acrylamide, 7M urea, 1x TBE gel. To visualize the probe, the gel was 
exposed for 1min to an autoradiographic film (Hyperfilm MP). The transcript was cut out of 
the gel using the film as a guide template. The gel slice was cut in pieces and the labeled RNA 
was eluted in 400μl elution buffer for either 2h at 42°C or overnight at 37°C. The supernatant 
was transferred to a new tube, and the gel slices were washed with 200μl elution buffer at 
42°C for 30min. The supernatant was added to the new tube and 1/10 volume of 3M Na-
acetate and 2.5 volumes ethanol were added to the sample, and the probe was precipitated 
at –20°C for 30min. The labeled RNA was collected by centrifugation at 18000g for 30min, 
dried, and resuspended in RNAse free water. The specific activity of the probe was measured 
in a scintillation counter.
Protein binding and crosslink
20μg protein extract or the corresponding amount of the chromatography fractions, 10μg 
heparin sulfate, 1x reaction buffer were mixed in dilution buffer and incubated for 30min at 
30°C. A volume corresponding to 50000cpm of probe was added to the crosslinking reaction 
and incubated for 10min at 30°C. The tubes were put on ice, covered by a glass plate and 
crosslinking was achieved by a dose of 2700mJ/cm2 with 312nm UV-light in a Strata linker 
(Stratagen). The non-crosslinked RNA was digested with 10μg RNase A per reaction at 37°C 
for 20min. The protein-RNA complexes were boiled for 5min with 1x protein loading dye 
and separated on a 10% SDS-polyacrylamide gel. The radioactively labeled protein-RNA 
complexes were visualized by phosphor imaging. Adapted from: (McBratney and Sarnow 
1996)
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4.2.12 Staining of the protein gels
Silver staining
The protein gel was fixed for 30min in a 45% methanol/ 5% acetic acid solution and washed 
afterwards for 1h with several changes of water. The gel was sensitized for 2min with a 
0.02% Sodium thio sulfate solution, rinsed twice with water and stained with a 0.1% Ag 
nitrate solution for 20min. The gel was again rinsed twice with water and once with developer 
(12.5g NaCO3, and 150μl formaldehyde in 500ml water). The gel was developed until the 
bands were clearly visible, stopped by adding fixing solution and dried in a gel dryer. 
Coomassie blue staining
The protein gel was fixed for 30min in a 45% methanol/ 5% acetic acid solution and stained 
with Coomassie blue staining solution (Invitrogen) for 1h at room temperature. The gel was 
destained with water until bands were clearly visible against the background.
4.2.13 Chromatography
Selection of the appropriate chromatography matrices
2x 100μl of the various chromatographic media (50% slurry): Q-Sepharose, Red-Sepharose, 
Blue-Sepharose, Heparin-Sepharose and Phenyl-Sepharose, were washed three times with 
water. One part was equilibrated with 50mM Tris/HCl pH8.0 and 100mM KCl, the other 
part with 50mM Tris/HCl pH8.0 and 500mM KCl. To each matrix, 150μg lysate was added 
containing either 100mM or 500mM KCl. The protein was adsorbed for 1h at 4°C. The 
beads were spun down at 2000rpm for 2min and the supernatants were transferred to new 
tubes. For the UV-Crosslinking experiments 10μl of the supernatants were used.
Heparin-Sepharose chromatography (FPLC)
A HR10/30 column was packed with Heparin-Sepharose and equilibrated with buffer A/ 
10% buffer B (= 100mM KCl) and 50mg of protein were loaded onto the column. The flow 
rate was 4ml per minute. The column was washed for 15 minutes with this buffer, and then 
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buffer B concentration was raised to 25% (= 250mM KCl) for 7.5min, followed by a further 
increase to 100% (= 1M KCl) for 7.5min. The column was re-equilibrated with 10% buffer 
B. 4ml fractions were collected. The 1M KCl fractions were pooled and dialyzed against 
buffer A supplemented with 100mM KCl.
Affinity chromatography
Streptavidin sepharose was pre-coated with a biotinylated RNA-oligomer Bio-CDE-K in 
PBS for 20min at room temperature, with uncoated streptavidin beads serving as control. 
The beads were washed three times with PBS and afterwards equilibrated with buffer A 
supplemented with 100mM KCl. Fractions from the heparin sepharose column were added 
to the beads and incubated overnight at 4°C. The beads were washed with 5 bead volumes 
of buffer A containing 500mM KCl and the proteins were eluted with three bead volumes 
of buffer B. The same procedure was used for affinity-pulldown from cytoplasmic extracts 
using bio-CDE-O, bio-sNRE and bio-IL3-UTR.
Mono-Q chromatography (FPLC)
The affinity eluate was diluted 1:10 in buffer A and loaded onto a HR5/5 column loaded with 
Q-sepharose beads at a flow rate of 1ml/min with buffer A, 10% buffer B. The column was 
washed with 5 column volumes of this buffer and afterwards buffer B concentration was 
raised to 25% and washed again with 5 column volumes. The bound proteins were eluted 
with a gradient from 25%-100% buffer B over 8min. The column was cleaned with 8 volumes 
100% buffer B and re-equilibrated with 10% buffer B. 500μl fractions were collected. 
4.2.14 Mass spectrometry
The samples were precipitated with 15% tri-chloro-acetic-acid at 4°C for 30 minutes, 
precipitated by centrifugation for 15min at 18000g, and resuspended in 20μl sample buffer 
containing 10mM DET. The pH was adjusted to 7.5 with 1M tris/HCl pH 8.0 and reduced 
by boiling for 10min at 95°C. After the sample cooled down to room temperature, it was 
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reduced with iodoacetamide for 60min at room temperature in the dark. The samples were 
analysed by a 7.5 to 15% gradient SDS-PAGE, followed by coomassie staining.
Mass spectrometry was performed by Stefan Evers and Daniel Röder at F. Hoffmann-La 
Roche, Ltd as in: (Grunenfelder et al. 2001; Lee et al. 2002). In short: Protein bands were 
cut out of the gel, destained and digested with trypsin. The masses of the peptides after 
proteolytic digestion were determined with a matrix-assisted laser desorption ionization 
time-of-flight mass spectrometer (Reflex3, Bruker, Billerica, MA). Protein homology 
searches were done by Blast-2. If the identification of a band could not by achieved by this 
method, it was determined by nano-spray-tandem mass spectrometry on a quadrupole time-
of-flight mass spectrometer (Qstar Pulsar 1;ABI/MDS Sciex, Toronto, Canada).
4.2.15 Preparation of recombinant nucleolin
One liter of High 5 cells were infected with 150ml viral supernatant and incubated for 42h 
at 28°C. The cells were collected by centrifugation at 600g for 10min. The supernatant was 
retained at 4°C for further infections at 4°C. The cells were washed once in PBS, spun 
down at 600g for 10min and the PBS was removed completely. The cells were lysed in four 
pellet volumes of extraction buffer for 30min at 4°C and sonicated three times for 10sec. 
The insoluble fraction was removed by centrifugation at 20000 rpm in a Sorvall SS34 rotor 
for 30min. The supernatant was transferred to a new tube and 2ml of GSH-sepharose beads 
(50% slurry) were added and GST-Nucleolin was allowed to bind overnight at 4°C tumbling 
end over end. The beads were collected at 1000g for 2min and the supernatant was removed. 
The beads were washed with 10 bead volumes of GST-wash buffer, 10 bead volumes of 
GST-wash buffer 500 and again with 10 bead volumes of GST-wash buffer. The column 
was equilibrated with 4 volumes of TeV-buffer, and nucleolin was eluted in 1ml TeV-buffer 
containing 500U TeV-protease (Invitrogen) for 1h at 4°C by tumbling end over end. The 
beads were again washed with 1ml TeV-buffer and the eluates were pooled. The eluates 
were supplemented with 10% glycerol and frozen as 50μl aliquots in liquid nitrogen. The 
recombinant nucleolin was stored at –80°C.
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4.2.16 RNA-electrophoretic mobility shift assay
Probe preparation
The templates for transcription were obtained by PCR amplification of the pSP73 O, Om2, 
Om3, Om5, Om6 and L vectors with the primers pSP73-100 and TV247, Om2AS, Om3AS, 
Om5AS, Om6AS or M2355 respectively. The templates of sNRE and mNRE were obtained 
by annealing the oligonucleotide pairs SP6-sNREs and SP6-sNREa or SP6-NS26A18Cs 
and SP6-NS26A18Ca. The radioactively labeled transcripts were generated by in vitro 
transcription with the SP6 maxiscript kit (Ambion) in the presence of 40μCi α[32P]UTP, 
following the manufacturers protocol. The probes were gel purified as described in 3.2.11.4
Sample preparation
Cytoplasmic extracts from Raw264.7 or THP-1 cells were obtained by lysis with EMSA lysis 
buffer for 10min on ice. The insoluble fraction was precipitated in an Eppendorf table top 
centrifuge at 600g for 10min, and the cytoplasmic extract was transferred to an new tube. 
Binding reaction and electrophoresis
RNA-Protein complexes were formed for 30min at 4°C with either 10μg cytoplasmic extract 
or 100ng purified nucleolin in EMSA buffer supplemented with 1μg/reaction of heparin 
sulfate and polyAU (Sigma), and 10 kcpm of 32P labeled transcript. In shift assays with 
recombinant protein, also 1μg of BSA was also added per reaction. For supershift assays 
0.5μg of anti-GST-antibody (Pharmingen) or anti-nucleolin-antibody (MS3 Santa Cruz) 
were added 30min before the addition of the radioactive probe. 
The complexes were electrophoresed on a 4% polyacrylamide gel containing 45mM Tris-
borate pH8.0 in EMSA running buffer.
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4.2.17 RNA-IP
Preparation of the RNA-IP
Approximately 108 cells were washed 3 times with ice cold PBS and pelleted in a centrifuge 
at 1200 rpm for 5min. The pellets were resuspended in 1 volume of RNA-IP lysis buffer 
by repeated pipetting and incubated 5min at 4°C. Aliquots of 250μl were frozen in liquid 
nitrogen and stored at –150°C. Before use, samples were thawed on ice and centrifuged for 
10min at 14000g. The supernatant was transferred to a new tube. This step was repeated 
once. Protein G sepharose beads (Amersham Pharmacia) were washed 3 times with water 
and incubated for at least 1h with 4 volumes of buffer NT2 containing 5% BSA. 4μg of anti 
nucleolin antibody (MS3 Santa Cruz) or 4μg of anti-tubulin antibody (Santa Cruz) were 
added to 250μl of slurry resulting in 50μl pelleted bead volume and tumbled end over end 
for 18h at 4°C. The antibody-coated beads were washed 4 times with 1ml buffer NT2 and 
resuspended in 850μl NT2 supplemented with 30μl 0.5M EDTA, 10μl 100mM DTT, 5μl 
VRC (200mM, Sigma), and 5μl RNAseIn (200U). The beads were mixed shortly before 
adding 100μl of RNA-IP lysate. The sample was mixed again shortly and centrifuged at 
2500 rpm for two minutes. 100μl of supernatant representing the total cellular mRNA, 
were transferred to a new tube and tumbled end over end alongside the IP-reaction at 25°C 
for 2h. The beads were washed 10 times with 1ml buffer NT2 and resuspended in 100μl 
NT2 buffer supplemented with 0.1% SDS and 30μg proteinase K (Tenenbaum et al. 2002). 
The reaction was incubated 30min at 55°C. The RNA was extracted with the RNeasy kit 
(Qiagen) following the manufacturers protocol. 350μl of buffer RLT containing 2-mercapto-
ethanol were added and the reaction was mixed shortly. The beads were pellet at 14000g for 
2min and the supernatant was transferred to a new tube. After addition of 250μl ethanol, the 
sample was loaded onto the RNeasy spin column. After washing, the RNA was eluted with 
30μl RNAse-free water.
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Reverse transcription
For reverse transcription 5μg of total RNA or a corresponding amount from the RNA-IP 
were mixed with 100pmol oligo dT
15
 primer and adjusted to a total volume of 13μl with 
H
2
O. The samples were heated to 65°C for 5min and put on ice for 2min. 4μl of 5x 1st strand 
buffer, 1μl 100mM DTT, 1μl (40U) RNAseIn and 1μl Superscript III reverse transcriptase 
(Invitrogen) were added. The reaction was mixed and incubated at 50°C for 1h and the RT 
inactivated at 70°C for 15min. The RNA was removed by adding 1μl of DNAse-free RNAse 
(Roche) for 20min at 37°C. The reaction was stored at –20°C
PCR amplification of the immunoprecipitated cDNAs
To amplify the targets, 2µl cDNA was added to a mix containing 1x PCR Buffer (Qiagen), 
2.5mM forward primer and 2.5mM reverse primer, 400μM of each dNTP and 0.2U of Taq 
polymerase (Qiagen). 35 cycles with 45sec denaturation at 94°C, 45sec annealing at 55°C 
and 45sec extension at 72°C were performed, followed by 10min of elongation at 72°C. 
TNF-α was detected with the primers BR5 and BR6, IL-6 with BR16 and BR17, IL-10 with 
BR18 and BR19, and GAPDH with M2352 and M2353. The PCR products were analyzed 
on a 1% Agarose-TAE gel.
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